Citrus Sinensis ID: 001761

Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------102
MMKPKPFKEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVISSSDHEKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQDSSVSSKKTVMGSLTKQHSQVKVIGNALSAPSSMATESNLLSVSCTGFADQDLEATFSQSMPSMYMDAPVVSKDGAIEAPTAQTRNESNSDVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAYDLLLPKESAWSTKGAPLCTNNLNQGKESSVRHSLSSDEMLRSTNSGIGMPLSLEENREERAEIHMKRESSLEATAVPSQQNLLSALSDENKTQLRTKEDFRVQSLQNMKLSTVFRGKIFRFSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTTHDREAGLCTVSQFPMQSVQMSSADEPSQFINPLGGLQSSSPQTMVHKIDDITRSDNLRDEANQTSAHNKRARISEDEDHDTLPGVHLKDPHRSTNYNGDSMSKDNGEVPHIGSDVAAVIEDLVEQTSKVQDLKSPERSECDKSLFPSDCSVLGQNHTDFNSVIGLSRQWSNRTLKKNDIQNPFNSKGVRSGIYEPFSETQTESQVVSYEEDLSGRQKIIDRAKSEAACLEKLVQLRERS
ccccccccccEEEEEcccccHHHHHHHHHHHHHcccEEEEEccccccccccEEEEcccccHHHHHHHHcccccccHHHHHHHHHHccccccccccccccccccEEEEcccccHHHHHHHHHHHHcccEEEEcccccccEEEEcccccHHHHHHHHHccccEEEHHHHHHHHHHcccccccccccccccccEEEEccccHHHHHHHHHHHHHHccEEcccccccccEEEEEccccccccccccccccHHHHHHHHccccEEEcccHHHHHHHHccccccccccccccccccccccccccccccccHHccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEcccHHHHHHHHHHHHHcccEEEEccccccEEEEEccccHHHHHHHHHHHHccccEEEcccHHHHHHHHcccccHHcccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccccccHHHHHcccccccEEcccEEEEEcccccHHHHHHHHHHHHccccEEEEccccccEEEEEccccccccccccccccEEcHHHHHHHHHHcccccccccccccccccccccccccccEEEEccccHHHHHHHHHHHHHcccEEEcccccccEEEEEEccccHHHHHHHHccccEEcHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHccHHHHHHHHHHHHHHc
cccccHccccEEEEccccccHHHHHHHHHHHHHcccEEEEEccccccccccEEEEcccccHHHHHHHHccccEccccEEHHHHccccccccccccEHHHHcccEEEEccccHHHHHHHHHHHHHHccEEcccccccEEEEEEcccccHHHHHHHHHcccccccHHHHHHHHHHccccccccccccccccEEEEEccccHHHHHHHHHHHHHccccEccccccccEEEEEEccccccccccccccccHHHHHHHHcccccEEcHHHHHHHHHccccccHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHcccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEcccHHHHHHHHHHHHHcccEEEcccccccEEEEEccccHHHHHHHHHHHcccccEEEcHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHccccccccccHHccccccccccccccccccccccccccccccccccccccccHccccccccccccccccccHcHHEEccccccHHcHHHHHHHHHHccccEcccccccccEEEEEccccccHHHHHcccccccHHHHHHHHHcccccccccccccccccccccccccccEEEEEEcccHHHHHHHHHHHHHHcccEEEEEEcccEEEEEcccccHHHHHHHHccccEccHHHHHHHHHHcccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccHcHHHHHHHHcccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccEcccHHHcccHHHHHHccccHHHHHHHHHHHHHcc
MMKPKPFKEAKVYMSRNLVAPEIFDALLDALKLNgaevelccdpsrtgpndfhvisssdheKFEDLRAKgcnllgpqcvlscakenralpkqgftcclAMDGVKviasgfdvdekFKIEKLVTAMGgvlqtkatLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCwnehrvvpqesykvlpfsglmicvtripadERKEMEKLIVQnggkyspeltkKCTHLICDISftiyflnfpytpegdkfkvakRWGHIHIINRKWFDQSMARRAClneesytvqdssvsskktvmgsltkQHSQVKVIGnalsapssmatesnllsvsctgfadqdleatfsqsmpsmymdapvvskdgaieaptaqtrnesnsdvcvandsqsedndlylsdcrIVLVGFEASEMRKLVNMVRrgggsryvsynNGLTHIVVGTLSEADKREVRSLASLGIIQVVKstwledcdRERREISILQRHVAydlllpkesawstkgaplctnnlnqgkessvrhslssdemlrstnsgigmplsleENREERAEIHMKressleatavpsQQNLLSALSDenktqlrtkEDFRVQSLQnmklstvfrgkifrfsnsfpedrRAEIVQWVNQgrgevvnddakqnVHFTIechgvipksadasettyVSSHWIRscledgclldvgshilysplhcqtplpgferfRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAgglkyeaackwgipsitsEWIYECVRqnevvsldhfspkevtthdreaglctvsqfpmqsvqmssadepsqfinplgglqssspqtmvhkidditrsdnlrdeanqtsahnkrarisededhdtlpgvhlkdphrstnyngdsmskdngevphigsDVAAVIEDLVEQTskvqdlkspersecdkslfpsdcsvlgqnhtdfnSVIGLSrqwsnrtlkkndiqnpfnskgvrsgiyepfsetqtesQVVSYEEDLSGRQKIIDRAKSEAACLEKLVQLRERS
mmkpkpfkEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVISSSDHEKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQnggkyspelTKKCTHLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIinrkwfdqSMARRACLNEesytvqdssvssKKTVMGSLTKQHSQVKVIGNALSAPSSMATESNLLSVSCTGFADQDLEATFSQSMPSMYMDAPVVSKDGAIEAPtaqtrnesnsdvcvandsqsedndlylsDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLAslgiiqvvkstwledcdRERREISILQRHVAYDLLLPKESAWSTKGAPLCTNNLNQGKESSVRHSLSSDEMlrstnsgigmplsLEENREERAEIHMKressleatavpSQQNLLSALSDENKTQLRTKEdfrvqslqnmklstvfrgkifrfsnsfpedrRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTTHDREAGLCTVSQFPMQSVQMSSADEPSQFINPLgglqssspqTMVHKIDDitrsdnlrdeanqtsahnkrarisededhdtlpgvhlkdphrstnYNGDSMSKDNGEVPHIGSDVAAVIEDLVEQtskvqdlkspersecdkslfpsdcsvlgqnhTDFNSVIGLSRQWSnrtlkkndiqnpfnskgvrsgiyepfsetqtesqvVSYEEDLSGRQKIIDRAKSEAACLEKlvqlrers
MMKPKPFKEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVISSSDHEKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQDSSVSSKKTVMGSLTKQHSQVKVIGNALSAPSSMATESNLLSVSCTGFADQDLEATFSQSMPSMYMDAPVVSKDGAIEAPTAQTRNESNSDVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAYDLLLPKESAWSTKGAPLCTNNLNQGKESSVRHSLSSDEMLRSTNSGIGMPLSLEENREERAEIHMKRESSLEATAVPSQQNLLSALSDENKTQLRTKEDFRVQSLQNMKLSTVFRGKIFRFSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTTHDREAGLCTVSQFPMQSVQMSSADEPSQFINPLGGLQSSSPQTMVHKIDDITRSDNLRDEANQTSAHNKRARISEDEDHDTLPGVHLKDPHRSTNYNGDSMSKDNGEVPHIGSDVAAVIEDLVEQTSKVQDLKSPERSECDKSLFPSDCSVLGQNHTDFNSVIGLSRQWSNRTLKKNDIQNPFNSKGVRSGIYEPFSETQTESQVVSYEEDLSGRQKIIDRAKSEAACLEKLVQLRERS
***********VYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVI******KFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLN*************************************************VSCTGF*******************************************************DLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAYDLLLPKESAWSTKGAPLC**************************************************************************************LQNMKLSTVFRGKIFRFSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTT****AGLCTV*********************************************************************************************************AAVI*****************************CSVLGQNHTDFNSVIGLSRQWS*********************************************************************
***PKPFKEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVISSSDHEKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQDSSVSSK**************************************************************************AQTRNESNSDVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAYDLLLPKESAWSTKGAPLCTNNL*************************GMPLSLEENREERAEIHMKRESSLEATAVPSQQNLLSALSDENKTQLRTKEDFRVQSLQNMKLSTVFRGKIFRFSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFS**********************************************************************************************************************************************************************************************************************************************VQL****
MMKPKPFKEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVISSSDHEKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLN***********************QHSQVKVIGNALSAPSSMATESNLLSVSCTGFADQDLEATFSQSMPSMYMDAPVVSKDGAIEAPT**********VCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAYDLLLPKESAWSTKGAPLCTNNLNQ*************EMLRSTNSGIGMPLSLEENREERAEIHMKRESSLEATAVPSQQNLLSALSDENKTQLRTKEDFRVQSLQNMKLSTVFRGKIFRFSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTTHDREAGLCTVSQFPMQ*********PSQFINPLGGLQSSSPQTMVHKIDDITRSDNLRD****************DEDHDTLPGVHLKDPHRSTNYNGDSMSKDNGEVPHIGSDVAAVIEDLVEQT****************SLFPSDCSVLGQNHTDFNSVIGLSRQWSNRTLKKNDIQNPFNSKGVRSGIYEPF***************LSGRQKIIDRAKSEAACLEKLVQLRERS
****KPFKEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVISSSDHEKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQD*****************************************************************************************DVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAYDLLLPKESAWSTKGAPLCTNNL**************************************************************************************KLSTVFRGKIFRFSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKE****************************************************************************************************************HIGSDVAAVIEDLV*******************SLFPSDCSVLGQNHTDFNSVIGLSRQWSNRTL**************************TESQVVSYEEDLSGRQKIIDRAKSEAACLEKLVQL****
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MMKPKPFKEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVISSSDHEKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQDSSVSSKKTVMGSLTKQHSQVKVIGNALSAPSSMATESNLLSVSCTGFADQDLEATFSQSMPSMYMDAPVVSKDGAIEAPTAQTRNESNSDVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAYDLLLPKESAWSTKGAPLCTNNLNQGKESSVRHSLSSDEMLRSTNSGIGMPLSLEENREERAEIHMKRESSLEATAVPSQQNLLSALSDENKTQLRTKEDFRVQSLQNMKLSTVFRGKIFRFSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTTHDREAGLCTVSQFPMQSVQMSSADEPSQFINPLGGLQSSSPQTMVHKIDDITRSDNLRDEANQTSAHNKRARISEDEDHDTLPGVHLKDPHRSTNYNGDSMSKDNGEVPHIGSDVAAVIEDLVEQTSKVQDLKSPERSECDKSLFPSDCSVLGQNHTDFNSVIGLSRQWSNRTLKKNDIQNPFNSKGVRSGIYEPFSETQTESQVVSYEEDLSGRQKIIDRAKSEAACLEKLVQLRERS
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

Original result of BLAST against SWISS-PROT Database

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query1017 2.2.26 [Sep-21-2011]
Q800K6 1513 DNA topoisomerase 2-bindi N/A no 0.794 0.534 0.243 1e-47
Q92547 1522 DNA topoisomerase 2-bindi yes no 0.641 0.428 0.245 1e-45
Q7ZZY3 1513 DNA topoisomerase 2-bindi N/A no 0.794 0.534 0.242 3e-45
Q6ZQF0 1515 DNA topoisomerase 2-bindi yes no 0.624 0.419 0.242 7e-43
Q07139913 Protein ECT2 OS=Mus muscu no no 0.202 0.225 0.267 3e-16
Q9H8V3914 Protein ECT2 OS=Homo sapi no no 0.232 0.258 0.253 5e-16
P32372648 S-M checkpoint control pr yes no 0.165 0.259 0.247 2e-09
O04251 1329 BRCT domain-containing pr no no 0.140 0.107 0.269 2e-07
Q6NZQ4 1056 PAX-interacting protein 1 no no 0.143 0.138 0.295 9e-06
Q6ZW49 1069 PAX-interacting protein 1 no no 0.143 0.136 0.295 9e-06
>sp|Q800K6|TOB1A_XENLA DNA topoisomerase 2-binding protein 1-A OS=Xenopus laevis GN=topbp1-A PE=1 SV=2 Back     alignment and function desciption
 Score =  192 bits (488), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 242/994 (24%), Positives = 406/994 (40%), Gaps = 186/994 (18%)

Query: 63  FEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCC-LAMDGVKVIASGFDVDEKFKIEKL 121
           F  L+  GC ++GPQ V+ C +  R +P+  +    +AM  V +  +  D + +  +   
Sbjct: 68  FSHLKKLGCRIVGPQVVIFCMENQRRVPRAEYPVYNMAMADVTISCTSLDKETREDVHHY 127

Query: 122 VTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNE--HRV--- 176
           V  MGG +     + V+ +I   V + KY  A + L+KPI+  +W+ + W +   R+   
Sbjct: 128 VQIMGGCVYRDLNVSVTHLIAGEVGSKKYLVAAS-LEKPILLPSWVKELWEKSNQRIIRY 186

Query: 177 --VPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPEL-TKKCTHLICDISF 233
             V    Y    F G  ICVT + + +RKE+++L   +GG+Y+ +L   + THLI   + 
Sbjct: 187 SDVNMTEYLCPIFRGCTICVTGLSSLDRKEVQRLTALHGGEYTGQLKMNESTHLIVQEA- 245

Query: 234 TIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQDSSVSSKKT 293
                      +G K++ A++W ++H I+ +WF  S+ +  C +E  Y ++ +S  + K+
Sbjct: 246 -----------KGQKYECARKW-NVHCISVQWFFDSIEKGFCQDETMYKIEPAS--TIKS 291

Query: 294 VMGSLTKQHSQVKVIGNALSAPSSMATESNLLSVSCTGFADQDLEATFSQSMPSMYMDAP 353
           V  + T      K     L   S ++     +S SC        E+ F+ +M S  +D P
Sbjct: 292 VPDTSTPTGGNSKPNSRTLYDVSQISN----ISTSCVN------ESAFNSAMASR-LDPP 340

Query: 354 VVSKDGAIEAPTAQTRNESNSDVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMV 413
             + +              N D+     S  +  D  L  CRI L GF   ++ KL  ++
Sbjct: 341 ADTLE--------------NLDI-----SSLQAPDDLLDGCRIYLCGFGGRKLDKLRKLI 381

Query: 414 RRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDC----DRERR 469
             GGG R+      +THI+VG   E  K+ +        +  VK  WL D       +  
Sbjct: 382 NNGGGVRFNQLTGDVTHIIVGETDEELKQFLNKTQHRPYVLTVK--WLLDSFAKGHLQPE 439

Query: 470 EISILQRHVAYDLLLPKESAWSTKGAPLCTNNLNQGKESSVRHSLSSDEMLRSTNSGIGM 529
           EI     +   ++  P E A           NL   K SS R                  
Sbjct: 440 EIYFHSSYQQTEMPSPFEPAI----------NLTANKMSSTRD----------------- 472

Query: 530 PLSLEENREERAEI---HMKRESSLEATAVPSQQNLLSALSDENKTQLRTKEDFRVQSLQ 586
           PL+   N +   ++   + +  S+L     P   N  S       +Q+   ED    + Q
Sbjct: 473 PLNHTRNHQADEDLLSQYTENNSTLIEDEHPKTSNTNSI------SQMSMHEDMTTCTSQ 526

Query: 587 N--MKLSTVFRGKIFRFSN----SFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECH 640
           +     ST+  G +F         F E+  A I+  + +  G+V++   +      I  +
Sbjct: 527 SGLADTSTIIEGGLFSRKQFMVLGFLEEDEACIIDIIKKSAGKVLSSQKR-----AIADY 581

Query: 641 GVIPKSADASETTY---VSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCV 697
            V+P      E+T    V++ W+  C+E   LLD  S+ L++P+     L G    R CV
Sbjct: 582 AVVPLLGCEVESTVGEVVTNAWLGMCIEQEKLLDPHSNALFTPVPF---LEGSTPLRECV 638

Query: 698 ---SQYEEKDRVLLRNLCFVLGAKFMEKLTKKV---------THLLCKFAGGLKYEAACK 745
              SQ+   +R  L  L  +LGAK  E   +K          THL+ K A G KYEAA K
Sbjct: 639 LSVSQFMGAERDSLVYLAGLLGAKVQEFFVRKANPKKGMFASTHLVLKDAEGSKYEAAKK 698

Query: 746 WGIPSITSEWIYECVRQNEVVSLDHFSPKEVTTHDREAGLCTVSQFPMQSVQMSSADEPS 805
           W +P++T  W+ +C R       D +    V   D++    + +  P Q++++ S   P 
Sbjct: 699 WNLPAVTMNWLLQCARTGRKADEDSYLVDNVPEEDKDESFISQTYKP-QAIRL-SMHAPC 756

Query: 806 QFINPLGGLQSSSPQTMVHKIDDITRSDNLRDEANQT--SAHNKRARISEDEDH--DTLP 861
              N    L  ++   +     D+ R    + +A Q+  S HNK  + S  E       P
Sbjct: 757 HLENHPEALTKAAVTPL-----DMNR---FKSKAFQSVISQHNKNPQTSGGESKVLQREP 808

Query: 862 GVHLKDPHR-------------------------STNYNGDSMSKDNGEVPHIGSDVAAV 896
            +HL  P +                           N    + S    EV  IG ++   
Sbjct: 809 SLHLDTPSKFLSKDKLFKPSFDVKDALAALETPGGPNQKNRTQSTPLSEV--IGRNLQLA 866

Query: 897 IEDLVEQTSKVQ---DLKSPERSECDKSLFPSDCSV-----LGQNHTDFNSV---IGLSR 945
           I +   QT+ V     LK+ E+ E D S    +  +     L +   + N +   +G   
Sbjct: 867 IANSTRQTAAVTASPQLKAAEKKEFDNSKLLINVVICVSKKLIKKQGELNGIAASLGAEY 926

Query: 946 QWS-NRTL-------KKNDIQNPFNSKGVRSGIY 971
           +W  + ++       ++ND+   + S   RSGIY
Sbjct: 927 RWCFDESVTHFIYHGRQNDMSREYKSVKERSGIY 960
Has dual roles in initiation of DNA replication, and regulation of checkpoint responses. Required for DNA replication initiation but not for the formation of pre-replicative complexes or the elongation stages. Necessary for the loading of replication factors onto chromatin, including gemc1, cdc45, DNA polymerases and components of the GINS complex such as ginsl/sld5. Binds chromatin in both S-phase cyclin-dependent kinase (S-CDK)-independent and S-CDK-dependent modes. Chromatin binding is required for the action of S-CDK, which in turn triggers the formation of preinitiation complexes of DNA replication. Its role in checkpoint activation is independent of the DNA replication role. In response to DNA damage, triggers the recruitment of checkpoint signaling proteins on chromatin, which activate the chek1 signaling pathway and block S-phase progression. Increases the kinase activity of atr to numerous substrates, and is required for the phosphorylation of Rad1.
Xenopus laevis (taxid: 8355)
>sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens GN=TOPBP1 PE=1 SV=3 Back     alignment and function description
>sp|Q7ZZY3|TOB1B_XENLA DNA topoisomerase 2-binding protein 1-B OS=Xenopus laevis GN=topbp1-B PE=2 SV=1 Back     alignment and function description
>sp|Q6ZQF0|TOPB1_MOUSE DNA topoisomerase 2-binding protein 1 OS=Mus musculus GN=Topbp1 PE=1 SV=2 Back     alignment and function description
>sp|Q07139|ECT2_MOUSE Protein ECT2 OS=Mus musculus GN=Ect2 PE=1 SV=2 Back     alignment and function description
>sp|Q9H8V3|ECT2_HUMAN Protein ECT2 OS=Homo sapiens GN=ECT2 PE=1 SV=4 Back     alignment and function description
>sp|P32372|RAD4_SCHPO S-M checkpoint control protein rad4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=rad4 PE=1 SV=2 Back     alignment and function description
>sp|O04251|Y4211_ARATH BRCT domain-containing protein At4g02110 OS=Arabidopsis thaliana GN=At4g02110 PE=1 SV=3 Back     alignment and function description
>sp|Q6NZQ4|PAXI1_MOUSE PAX-interacting protein 1 OS=Mus musculus GN=Paxip1 PE=1 SV=1 Back     alignment and function description
>sp|Q6ZW49|PAXI1_HUMAN PAX-interacting protein 1 OS=Homo sapiens GN=PAXIP1 PE=1 SV=2 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

Original result of BLAST against Nonredundant Database

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1017
255558572950 topbp1, putative [Ricinus communis] gi|2 0.922 0.987 0.604 0.0
359492364962 PREDICTED: DNA topoisomerase 2-binding p 0.925 0.978 0.598 0.0
302141765952 unnamed protein product [Vitis vinifera] 0.924 0.987 0.602 0.0
317106686918 JMS09K11.6 [Jatropha curcas] 0.898 0.995 0.589 0.0
356560149970 PREDICTED: DNA topoisomerase 2-binding p 0.943 0.989 0.581 0.0
145337666972 topoisomerase (DNA) II binding protein 1 0.935 0.978 0.527 0.0
34481719972 MEI1 protein [Arabidopsis thaliana] 0.935 0.978 0.526 0.0
297839591970 MEI1 protein [Arabidopsis lyrata subsp. 0.942 0.988 0.514 0.0
334183968955 topoisomerase (DNA) II binding protein 1 0.918 0.978 0.515 0.0
218185404978 hypothetical protein OsI_35425 [Oryza sa 0.907 0.943 0.474 0.0
>gi|255558572|ref|XP_002520311.1| topbp1, putative [Ricinus communis] gi|223540530|gb|EEF42097.1| topbp1, putative [Ricinus communis] Back     alignment and taxonomy information
 Score = 1209 bits (3128), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 614/1015 (60%), Positives = 742/1015 (73%), Gaps = 77/1015 (7%)

Query: 1    MMKPKPFKEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTGPNDFHVISSSDH 60
            M+  K F+ A V+MSRNLV PE+FDALLDAL+LNGA+V LCCDPSR GPND+H+ISS DH
Sbjct: 1    MLNTKTFRGANVFMSRNLVPPEVFDALLDALRLNGAQVLLCCDPSRNGPNDYHIISSPDH 60

Query: 61   EKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCCLAMDGVKVIASGFDVDEKFKIEK 120
            EKFEDLRAKGCNLLGPQCVLSCAKE+R LPKQGFTCCLAMDGVKV+ASGFD+DEK KIEK
Sbjct: 61   EKFEDLRAKGCNLLGPQCVLSCAKEHRTLPKQGFTCCLAMDGVKVLASGFDIDEKVKIEK 120

Query: 121  LVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRVVPQE 180
            LVTAMGG L TK +LDVSFVIVKNVLAAKYKWALNILKKP+VT NWLYQCWNEHRVVPQE
Sbjct: 121  LVTAMGGQLHTKTSLDVSFVIVKNVLAAKYKWALNILKKPVVTCNWLYQCWNEHRVVPQE 180

Query: 181  SYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNF 240
            SY+VLPFSGLMICVTRIPA                                         
Sbjct: 181  SYRVLPFSGLMICVTRIPA----------------------------------------- 199

Query: 241  PYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQDSSVSSKKTVMGSLTK 300
                 GDK+KVA+RWGHIHI+ RKWFDQS+ARRACLNEESY VQ  S SS K    S   
Sbjct: 200  -----GDKYKVAQRWGHIHIVMRKWFDQSVARRACLNEESYPVQGGSASSIKKS--SSMA 252

Query: 301  QHSQVKVIGNALSAPSSMATESNLLSVSCTGFADQDLEATFSQSMPSMYMDAPVVSKDGA 360
            QH    +IGN++S PS+   ESNL  +   G +D DLE T SQ+M SM+ D PV  K+  
Sbjct: 253  QH----IIGNSISVPSAAPAESNLPGLPGAGVSDLDLEPTLSQNMSSMFSDPPVSVKEWD 308

Query: 361  IEAPTAQTRNESNSDVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSR 420
             E P     NE+N D CVANDSQSED+DLYLS+CRI LVGFEASE+RKLVNMVRRGGGSR
Sbjct: 309  NEVPAVHPTNETNLDGCVANDSQSEDSDLYLSECRISLVGFEASELRKLVNMVRRGGGSR 368

Query: 421  YVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAY 480
            Y+S+N+ LTHIVVG  +E +K+E+R LA+LG+I VV+ TWLEDCDR+++E+ ++++H+AY
Sbjct: 369  YLSFNDKLTHIVVGAPTEVEKKELRGLAALGVIDVVRPTWLEDCDRQKKEVPVIRQHLAY 428

Query: 481  DLLLPKESAWSTKGAPLCTNNLNQGKESSVRHSLSSDEMLRSTNSGIGMPLSLEENREER 540
            DLLLPK+S  S KGA +    +NQGK +S   S+ SD++L S N G G   SLE +REE+
Sbjct: 429  DLLLPKDSMSSIKGAVV---GMNQGKVASAFSSIHSDQLLGSANFGNGKTSSLENSREEK 485

Query: 541  AEIHMKRESSLEATAVPSQQNLLSALSDENKTQLRTKEDFRVQSLQNMKLSTVFRGKIFR 600
             EI+M R  SLEAT   SQQN+ S ++DE K+  +T+ +    S QN K  TVF+GKIF 
Sbjct: 486  PEIYMSRSISLEATVRQSQQNIFSIVNDEKKSGKKTQPN---SSCQNQKPLTVFKGKIFC 542

Query: 601  FSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSHWI 660
            FSNSFP DRRAEI++WV+QG G++V D  K+NV+FTIECHG IP+    S+TTYVSSHW+
Sbjct: 543  FSNSFPADRRAEIIEWVSQGGGKMVEDHTKKNVNFTIECHGTIPRCMGGSQTTYVSSHWV 602

Query: 661  RSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFM 720
            RSCLED  LLDVG HI+YSPL CQ PLPGFE FRFC+SQYEEKDR+LLRNLCFVLGAKF+
Sbjct: 603  RSCLEDESLLDVGGHIIYSPLPCQIPLPGFENFRFCISQYEEKDRLLLRNLCFVLGAKFV 662

Query: 721  EKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTTHD 780
            EKLT+KVTHLLCKF  G KYEAACKWGI SITSEWIYECVRQNEVV+LD F PKEVT+ D
Sbjct: 663  EKLTRKVTHLLCKFTNGPKYEAACKWGICSITSEWIYECVRQNEVVALDRFRPKEVTSQD 722

Query: 781  REAGLCTVSQFPMQSVQMSSADEPSQFINPLGGLQSSSPQTMVHKIDDITRSDNLRDEAN 840
            +EAGLCTVSQFP Q+ +M S + PSQ I+    L+S+  QT    I       +  ++A 
Sbjct: 723  QEAGLCTVSQFPTQAARMISGENPSQLISQSRDLRSAPTQTGSIGI------FSFGEDAQ 776

Query: 841  QTSAHNKRARISEDEDHDTLPGVHLKDPHRSTNYNGDSMSKDNGEVPHIGSDVAAVIEDL 900
            +++ ++K+AR+ + +D +     HL DP  + N    + SKD     H   DVAA IEDL
Sbjct: 777  KSTKYSKKARLLKSDDQEAQLSFHLDDPVYTINSTRGNDSKDTAGSSHGVPDVAAAIEDL 836

Query: 901  VEQTSKVQDLKSPERSECD----------KSLFPSDCSVLGQNHTDFNSVIGLSRQWSNR 950
            +EQTSK+ D KS  +SE            + L+PSD  +LG++H   +SVIG+   W NR
Sbjct: 837  LEQTSKIHDQKSLGKSEYSMFASVESLTIEQLYPSD-PILGEDHGGSHSVIGVPNHWLNR 895

Query: 951  TLKKNDIQNPFNSKGVRSGIYEPFSETQTESQVVSYEEDLSGRQKIIDRAKSEAA 1005
            T K++D+ NP  S+ V  G+Y+ F+ETQTESQVV YEEDLSGRQ IIDR ++ ++
Sbjct: 896  TGKRDDLSNP--SREVNRGVYDNFTETQTESQVVLYEEDLSGRQMIIDRVRTRSS 948

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota
>gi|359492364|ref|XP_002284611.2| PREDICTED: DNA topoisomerase 2-binding protein 1-B-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|302141765|emb|CBI18968.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
>gi|317106686|dbj|BAJ53188.1| JMS09K11.6 [Jatropha curcas] Back     alignment and taxonomy information
>gi|356560149|ref|XP_003548358.1| PREDICTED: DNA topoisomerase 2-binding protein 1-A-like [Glycine max] Back     alignment and taxonomy information
>gi|145337666|ref|NP_177856.2| topoisomerase (DNA) II binding protein 1 [Arabidopsis thaliana] gi|332197842|gb|AEE35963.1| topoisomerase (DNA) II binding protein 1 [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|34481719|emb|CAD54082.1| MEI1 protein [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|297839591|ref|XP_002887677.1| MEI1 protein [Arabidopsis lyrata subsp. lyrata] gi|297333518|gb|EFH63936.1| MEI1 protein [Arabidopsis lyrata subsp. lyrata] Back     alignment and taxonomy information
>gi|334183968|ref|NP_001185418.1| topoisomerase (DNA) II binding protein 1 [Arabidopsis thaliana] gi|332197843|gb|AEE35964.1| topoisomerase (DNA) II binding protein 1 [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|218185404|gb|EEC67831.1| hypothetical protein OsI_35425 [Oryza sativa Indica Group] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

Original result of BLAST against Gene Ontology (AMIGO)

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1017
TAIR|locus:2031412972 MEI1 "AT1G77320" [Arabidopsis 0.713 0.746 0.476 7.8e-271
UNIPROTKB|Q92547 1522 TOPBP1 "DNA topoisomerase 2-bi 0.275 0.183 0.282 1.8e-43
UNIPROTKB|Q800K6 1513 topbp1-A "DNA topoisomerase 2- 0.451 0.303 0.251 2.4e-41
UNIPROTKB|G3X684 1524 TOPBP1 "Uncharacterized protei 0.280 0.187 0.271 5.4e-40
MGI|MGI:1920018 1515 Topbp1 "topoisomerase (DNA) II 0.210 0.141 0.297 1.7e-38
RGD|1562949 1516 Topbp1 "topoisomerase (DNA) II 0.257 0.172 0.275 1.3e-36
FB|FBgn0002878 1425 mus101 "mutagen-sensitive 101" 0.670 0.478 0.232 5.5e-31
UNIPROTKB|E1BSJ5508 TOPBP1 "Uncharacterized protei 0.246 0.494 0.298 3.1e-29
MGI|MGI:95281913 Ect2 "ect2 oncogene" [Mus musc 0.191 0.213 0.283 1.8e-14
RGD|1308524692 Ect2 "epithelial cell transfor 0.191 0.281 0.283 1.8e-14
TAIR|locus:2031412 MEI1 "AT1G77320" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 1572 (558.4 bits), Expect = 7.8e-271, Sum P(2) = 7.8e-271
 Identities = 369/775 (47%), Positives = 483/775 (62%)

Query:   245 EGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQDSSVSSKKTVMGSLTKQHSQ 304
             EGDK+KVA++WGHI I+ RKWF QS+ ++ CLNEESY V           +GS+      
Sbjct:   231 EGDKYKVARKWGHIQIVTRKWFQQSIDKKVCLNEESYPV-----------LGSIPLTRG- 278

Query:   305 VKVIG--NALSAPSSMATESNLLS-VSCTGFADQDLEATFSQSM-PSMYMDAPVVSKDGA 360
             V+ +G  N L    S AT S   S VSC    D D+EA+ SQ++ P+    +  V + G 
Sbjct:   279 VRDLGVHNGLEKFPSAATASAADSYVSCAQSRDSDIEASASQNVFPTSMNPSTDVKEPGG 338

Query:   361 IEAPTAQTRNESNSDVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSR 420
                PTA+ + E N D C A DS+SEDNDLYLSDCRI L+GFEASEMRKL  +VRRGGGSR
Sbjct:   339 --GPTARPQ-EQNIDGCTARDSESEDNDLYLSDCRIFLLGFEASEMRKLAKLVRRGGGSR 395

Query:   421 YVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVAY 480
             Y+  N  +THIVVGT SE++KRE RS+A+ G+IQVV  +WLEDCDRE++EI +   + A 
Sbjct:   396 YMLLNERMTHIVVGTPSESEKREARSVAASGVIQVVIPSWLEDCDREKKEIPVHNIYTAN 455

Query:   481 DLLLPKESAWSTKGAPLCTNNLNQGKESSVRHSLSSDEMLRSTNSGIGMPLSLEENREER 540
              L+LP++SA  TKG+    +++ Q K +  + ++  D   RS N   G    L +N+E  
Sbjct:   456 HLILPRDSACLTKGSFARMSSMEQTKNTHDQ-TMVYDSSSRSINVSNGPATLLGKNKEAM 514

Query:   541 AEIHMKRESSLEATAV-PSQ-QNLLSALSDENKTQLRTKEDFRVQSLQNMKLSTVFRGKI 598
              E   K E       V P+Q + L+S ++ E+K Q   + +F  Q+ Q  K S+VF+G+ 
Sbjct:   515 QEFGRKDEIHTGRKIVSPTQKETLISLVTCESKEQRSIQCEFSGQNDQERK-SSVFKGET 573

Query:   599 FRFSNSFPEDRRAEIVQWVNQGRGEVVNDDAKQNVHFTIECHGVIPKSADASETTYVSSH 658
             F FS+SFPEDRR +IV+WVNQG GEVVND    N HFTIECHG   +S + ++T YVSSH
Sbjct:   574 FCFSHSFPEDRRPQIVEWVNQGGGEVVNDPLINNAHFTIECHGGF-QSTETTQTIYVSSH 632

Query:   659 WIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAK 718
             W+R+CL+ GCLL V SHILYSPL CQTPLPGFE    C SQ+ EK+  LLRNL  VLGA 
Sbjct:   633 WVRNCLKVGCLLAVSSHILYSPLPCQTPLPGFESLCICSSQHNEKNVELLRNLSVVLGAD 692

Query:   719 FMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTT 778
             F+E+LT+KVTHL+C FA G KY  A KWGI S+T +W+YECVRQN+VV  D+F P+E+TT
Sbjct:   693 FVERLTRKVTHLICNFAKGDKYVRASKWGIISVTPDWLYECVRQNQVVCTDNFHPRELTT 752

Query:   779 HDREAGLCTVSQFPMQSVQMSSADE---PSQFINPLGGLQSSSPQTMVHKIDDITRSDNL 835
              DREAG    SQF  Q V M+S D    P         +QS + ++   K +   R   +
Sbjct:   753 QDREAG----SQFHTQFVPMASRDSMSLPVSHSEDREKIQSFAGKSGCGKGEVYNRLGEI 808

Query:   836 RDEANQTSAHNKRARISEDEDHDTLPGVHLKDPHRSTNYNGDSM--SKD--NG-EVPHIG 890
               E  QT    K   + + ++ D  P   L       +++GD +    D  +G EVP   
Sbjct:   809 GKE--QTFPSKKAKLLRDGQESDVFPVRELPSNCDRPSHSGDGIVTGYDVASGREVP--- 863

Query:   891 SDVAAVIEDLVEQTSKVQDLKSPERSECDKSLFPSDCSVLGQNHTDFNSVIGLSRQWSNR 950
              DVA  IEDL+EQTSK+QD KSP R   +K+ F    S   Q +T  +SV GLSR W NR
Sbjct:   864 -DVADTIEDLLEQTSKIQDQKSPGRI-LEKTHF----STSEQYNTGNHSVTGLSRHWINR 917

Query:   951 TLKKNDIQNPFNSKGVRSGIYEPFSETQTESQVVSYEEDLSGRQKIIDRAKSEAA 1005
               K +D+ +P       +  Y  FSETQTESQVV YEEDLSGRQ +IDR ++ ++
Sbjct:   918 VHKNDDMGSPPGD--ATTDTYGNFSETQTESQVVGYEEDLSGRQMLIDRVRTRSS 970
GO:0003713 "transcription coactivator activity" evidence=ISS
GO:0005622 "intracellular" evidence=IEA;ISS
GO:0005634 "nucleus" evidence=ISM
GO:0007131 "reciprocal meiotic recombination" evidence=TAS
GO:0007140 "male meiosis" evidence=IMP
GO:0006974 "response to DNA damage stimulus" evidence=ISS
GO:0007143 "female meiosis" evidence=IMP
UNIPROTKB|Q92547 TOPBP1 "DNA topoisomerase 2-binding protein 1" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|Q800K6 topbp1-A "DNA topoisomerase 2-binding protein 1-A" [Xenopus laevis (taxid:8355)] Back     alignment and assigned GO terms
UNIPROTKB|G3X684 TOPBP1 "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
MGI|MGI:1920018 Topbp1 "topoisomerase (DNA) II binding protein 1" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
RGD|1562949 Topbp1 "topoisomerase (DNA) II binding protein 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
FB|FBgn0002878 mus101 "mutagen-sensitive 101" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
UNIPROTKB|E1BSJ5 TOPBP1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
MGI|MGI:95281 Ect2 "ect2 oncogene" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
RGD|1308524 Ect2 "epithelial cell transforming sequence 2 oncogene" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Original result from the STRING server

Fail to connect to STRING server

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against CDD database part I

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1017
pfam1273863 pfam12738, PTCB-BRCT, twin BRCT domain 3e-23
pfam1273863 pfam12738, PTCB-BRCT, twin BRCT domain 9e-20
pfam0053377 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain 2e-14
cd0002772 cd00027, BRCT, Breast Cancer Suppressor Protein (B 4e-10
smart0029278 smart00292, BRCT, breast cancer carboxy-terminal d 9e-10
pfam0053377 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain 2e-09
cd0002772 cd00027, BRCT, Breast Cancer Suppressor Protein (B 2e-07
cd0002772 cd00027, BRCT, Breast Cancer Suppressor Protein (B 5e-07
pfam0053377 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain 6e-07
pfam0053377 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain 7e-07
smart0029278 smart00292, BRCT, breast cancer carboxy-terminal d 7e-07
pfam1273863 pfam12738, PTCB-BRCT, twin BRCT domain 3e-06
smart0029278 smart00292, BRCT, breast cancer carboxy-terminal d 3e-06
cd0002772 cd00027, BRCT, Breast Cancer Suppressor Protein (B 1e-05
smart0029278 smart00292, BRCT, breast cancer carboxy-terminal d 2e-05
>gnl|CDD|193214 pfam12738, PTCB-BRCT, twin BRCT domain Back     alignment and domain information 
 Score = 93.4 bits (233), Expect = 3e-23
 Identities = 32/62 (51%), Positives = 39/62 (62%)

Query: 694 RFCVSQYEEKDRVLLRNLCFVLGAKFMEKLTKKVTHLLCKFAGGLKYEAACKWGIPSITS 753
             CVS Y   DR  L+ L   LGA++ + LTKKVTHL+CK   G KYE A KWGIP ++ 
Sbjct: 2   VICVSGYSGDDRKYLQKLIEALGAEYSKDLTKKVTHLICKRGEGEKYEKAKKWGIPVVSH 61

Query: 754 EW 755
            W
Sbjct: 62  LW 63

This is a BRCT domain that appears in duplicate in most member sequences. BRCT domains are peptide- and phosphopeptide-binding modules. BRCT domains are present in a number of proteins involved in DNA checkpoint controls and DNA repair. Length = 63
>gnl|CDD|193214 pfam12738, PTCB-BRCT, twin BRCT domain Back     alignment and domain information
>gnl|CDD|215978 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain Back     alignment and domain information
>gnl|CDD|237994 cd00027, BRCT, Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|214602 smart00292, BRCT, breast cancer carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|215978 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain Back     alignment and domain information
>gnl|CDD|237994 cd00027, BRCT, Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|237994 cd00027, BRCT, Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|215978 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain Back     alignment and domain information
>gnl|CDD|215978 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain Back     alignment and domain information
>gnl|CDD|214602 smart00292, BRCT, breast cancer carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|193214 pfam12738, PTCB-BRCT, twin BRCT domain Back     alignment and domain information
>gnl|CDD|214602 smart00292, BRCT, breast cancer carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|237994 cd00027, BRCT, Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|214602 smart00292, BRCT, breast cancer carboxy-terminal domain Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

Original result of HHsearch against CDD database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 1017
KOG1929811 consensus Nucleotide excision repair factor NEF2, 100.0
KOG1929811 consensus Nucleotide excision repair factor NEF2, 99.87
KOG3524850 consensus Predicted guanine nucleotide exchange fa 99.73
PF1273863 PTCB-BRCT: twin BRCT domain; PDB: 3PA6_A 3KTF_C 2W 99.55
PF1273863 PTCB-BRCT: twin BRCT domain; PDB: 3PA6_A 3KTF_C 2W 99.39
PF0053378 BRCT: BRCA1 C Terminus (BRCT) domain; InterPro: IP 99.29
PF0053378 BRCT: BRCA1 C Terminus (BRCT) domain; InterPro: IP 99.26
KOG3226508 consensus DNA repair protein [Replication, recombi 99.17
smart0029280 BRCT breast cancer carboxy-terminal domain. 99.04
cd0002772 BRCT Breast Cancer Suppressor Protein (BRCA1), car 99.04
smart0029280 BRCT breast cancer carboxy-terminal domain. 99.01
cd0002772 BRCT Breast Cancer Suppressor Protein (BRCA1), car 98.96
KOG3524850 consensus Predicted guanine nucleotide exchange fa 98.93
KOG3226508 consensus DNA repair protein [Replication, recombi 98.92
KOG0966881 consensus ATP-dependent DNA ligase IV [Replication 98.58
KOG4362684 consensus Transcriptional regulator BRCA1 [Replica 98.5
KOG0966881 consensus ATP-dependent DNA ligase IV [Replication 98.46
PLN03122 815 Poly [ADP-ribose] polymerase; Provisional 98.37
KOG35481176 consensus DNA damage checkpoint protein RHP9/CRB2/ 98.33
PLN03122815 Poly [ADP-ribose] polymerase; Provisional 98.3
PLN03123 981 poly [ADP-ribose] polymerase; Provisional 98.25
PLN03123981 poly [ADP-ribose] polymerase; Provisional 98.16
KOG4362684 consensus Transcriptional regulator BRCA1 [Replica 98.12
KOG35481176 consensus DNA damage checkpoint protein RHP9/CRB2/ 97.98
KOG2043896 consensus Signaling protein SWIFT and related BRCT 97.61
PRK14350669 ligA NAD-dependent DNA ligase LigA; Provisional 97.56
PRK06195309 DNA polymerase III subunit epsilon; Validated 97.55
PRK06063313 DNA polymerase III subunit epsilon; Provisional 97.48
COG0272667 Lig NAD-dependent DNA ligase (contains BRCT domain 97.43
PRK07956665 ligA NAD-dependent DNA ligase LigA; Validated 97.42
PRK14351689 ligA NAD-dependent DNA ligase LigA; Provisional 97.34
PRK14350669 ligA NAD-dependent DNA ligase LigA; Provisional 97.25
TIGR00575652 dnlj DNA ligase, NAD-dependent. The member of this 97.22
PRK06063313 DNA polymerase III subunit epsilon; Provisional 97.16
PRK06195309 DNA polymerase III subunit epsilon; Validated 97.15
PRK14351689 ligA NAD-dependent DNA ligase LigA; Provisional 97.09
PRK07956665 ligA NAD-dependent DNA ligase LigA; Validated 97.08
COG0272667 Lig NAD-dependent DNA ligase (contains BRCT domain 96.98
KOG2481570 consensus Protein required for normal rRNA process 96.89
TIGR00575652 dnlj DNA ligase, NAD-dependent. The member of this 96.89
KOG2481570 consensus Protein required for normal rRNA process 96.49
COG5163591 NOP7 Protein required for biogenesis of the 60S ri 96.21
COG5275276 BRCT domain type II [General function prediction o 95.85
KOG0323635 consensus TFIIF-interacting CTD phosphatases, incl 95.69
COG5163591 NOP7 Protein required for biogenesis of the 60S ri 95.55
KOG0323635 consensus TFIIF-interacting CTD phosphatases, incl 95.43
KOG2043896 consensus Signaling protein SWIFT and related BRCT 95.42
COG5275276 BRCT domain type II [General function prediction o 95.16
KOG20931016 consensus Translesion DNA polymerase - REV1 deoxyc 93.08
PRK05601377 DNA polymerase III subunit epsilon; Validated 86.41
>KOG1929 consensus Nucleotide excision repair factor NEF2, RAD4/CUT5 component [Replication, recombination and repair] Back     alignment and domain information 
Probab=100.00  E-value=3.1e-46  Score=447.86  Aligned_cols=771  Identities=19%  Similarity=0.223  Sum_probs=476.4

Q ss_pred             CCCCCcEEEEcCCChhhHHHHHHHHHHcCCEEeecCCCceeEEEEcccChhhHHHHHhcCCCcEeehhHHHHHHHhcCc-
Q 001761           98 LAMDGVKVIASGFDVDEKFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEHRV-  176 (1017)
Q Consensus        98 ~~~~G~~i~~tgl~~~ek~~l~~lI~~mGG~~~~~lt~~vTHLI~~~~~s~KY~~A~~~~~i~IV~p~Wv~~c~~~~~~-  176 (1017)
                      ..|.|++||+||+++..+++|..++..|||.+..+++..+||||+++..+.||..|.+ .++++|..+|+...|..... 
T Consensus         8 ~~~~~v~~~~t~i~p~~~~~l~~~~~~~Gg~~~~~~t~~~thli~~~~~s~~~~~a~~-~~~~~~~~~wi~~~~d~~~~~   86 (811)
T KOG1929|consen    8 KPMSGVTFSPTGINPIKREELSKKFIKLGGIDFKDFTPSVTHLIVGSVTSSKYAAAHR-FDIKVLDSSWIDYIYDLWLLN   86 (811)
T ss_pred             cccCCceeccCcCCHHHHHHHHHHHHhcCceeeeccCCcCceeecccccccchhhhhc-CCCceecchHHHHHHHHhhhh
Confidence            5699999999999999999999999999999999999999999999999999977776 99999999999876655432 


Q ss_pred             ---cC----cccccccCCCCceEEEecCChhhHHHHHHHHHHhCCeecCCCCCCcceEEeccccccccccCCCCCCchhH
Q 001761          177 ---VP----QESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEGDKF  249 (1017)
Q Consensus       177 ---lp----~~~y~~~~F~Gl~I~~tG~~~~~r~~l~~lI~~~GG~~~~~l~~~~THLIv~~~~~~~~~~~~~~~~g~K~  249 (1017)
                         ++    .+.++++.|.||.||++||...+|.++..+|..+||++...|...+.|++...           ...++||
T Consensus        87 ~e~~~~~~l~~~~~~p~~~~~~Vc~tgl~~~eK~ei~~~v~k~gg~~~~~L~s~v~~~~~~~-----------~~~~~kY  155 (811)
T KOG1929|consen   87 KEIRLLDPLRDTMKCPGFFGLKVCLTGLSGDEKSEIKILVPKHGGTLHRSLSSDVNSLKILP-----------EVKTEKY  155 (811)
T ss_pred             ccCccCccchhhhcCCcccceEEEecccchHHHHHHHHHhhhcccEEehhhhhhhheeeecc-----------ccchHHH
Confidence               22    45688999999999999999999999999999999999999999988888832           2334999


Q ss_pred             HHHHhcCCeeEEccchHHHHHHhccCCCCCccccCCCCccccccccCcccccccchhhccCCCCCCCccccccccccccC
Q 001761          250 KVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQDSSVSSKKTVMGSLTKQHSQVKVIGNALSAPSSMATESNLLSVSC  329 (1017)
Q Consensus       250 ~~A~~~g~I~IVs~~WL~dSi~~g~~lde~~Y~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~s~~s~~~~ds~~~~i~~  329 (1017)
                      +.|.+| +++||+.+|+++|+.++.++++..|++.... .+...+..+....+           .+            .+
T Consensus       156 e~al~w-n~~v~~~~w~~~s~~~~~~~~~~~~e~~~~~-~~is~~~~~~~~~~-----------~~------------~~  210 (811)
T KOG1929|consen  156 EQALKW-NIPVVSDDWLFDSIEKTAVLETKPYEGAPVA-EAISGPIGSTLPKE-----------IL------------DG  210 (811)
T ss_pred             HHHHhh-CCccccHHHHhhhhccccccccccccccccc-ceeccCCccccccc-----------cc------------cc
Confidence            999999 5999999999999999999999999997642 11111111110000           00            00


Q ss_pred             CCcCCcchhhhcccCCCCcCCCCcccccCCCCCCCcccccCCCCCcccccCCCCCCCCcCcCCCcEEEEecCChHHHHHH
Q 001761          330 TGFADQDLEATFSQSMPSMYMDAPVVSKDGAIEAPTAQTRNESNSDVCVANDSQSEDNDLYLSDCRIVLVGFEASEMRKL  409 (1017)
Q Consensus       330 ~~~~~~D~~~t~s~~~~s~~s~~~~~~k~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~L~gc~~yl~GF~~~e~~~L  409 (1017)
                      ..+.-.|.|.+            +.+.       +     + ..+..     -++..+  ++++|.+|++||+..++..|
T Consensus       211 ~s~t~~~~~~~------------~~~~-------~-----n-~~~~p-----~~a~~~--~~~~c~v~~s~~~~~~~s~l  258 (811)
T KOG1929|consen  211 DSRTANDTWST------------SKVV-------T-----N-IKVLP-----FQAKIG--NLDDCLVETSGTTSRNRSAL  258 (811)
T ss_pred             cchhhhccccc------------hhcc-------c-----c-cccch-----hhhhcc--ccccceeeecCCcccchhHh
Confidence            00000111000            0000       0     0 00000     011222  68999999999999999999


Q ss_pred             HHHHHhCCCEEEeecCCCceEEEEcCCChhhHHHHHHhhhcCCcEEEcccHHHHHHhhccccccccchhh---ccccCCc
Q 001761          410 VNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRERREISILQRHVA---YDLLLPK  486 (1017)
Q Consensus       410 ~~lI~~~GG~v~~~ls~~vTHIIv~~~~~~~~~~vr~~~~~~~i~vV~~~WL~~Ci~~~~~l~e~~~~i~---~e~l~p~  486 (1017)
                      .+.++.+||..+..-++.++|++++.......+.+...+.......+.+.=+.-.++..-.-+...+...   .+..+|.
T Consensus       259 ~r~~~~g~~~~~~e~~e~~st~l~~~~~~~~~q~~d~~g~~~~~~n~~~~~~~~~s~~~~~~~~~~~k~~sF~~d~~~~~  338 (811)
T KOG1929|consen  259 SRLSNNGGSLRFLERLEETSTSLLGDFDPNLEQLWDDNGLKQSFQNLGPSVLGPNSKRRSKNSVLIFKNCSFIIDFEKPG  338 (811)
T ss_pred             HHhhhcccceeecccCccccchhhcccchHHHhhhhhccCcccccccCcccccccccccccccccccccccccccccccC
Confidence            9999999999999999999999999876654433333211111011111000000000000000000000   0000000


Q ss_pred             ccccccCCCCccccCCCCCCcccccccCCchhhhccCCCCCCCCCchhhhhHHHHHHhhccccccccccccccccccccc
Q 001761          487 ESAWSTKGAPLCTNNLNQGKESSVRHSLSSDEMLRSTNSGIGMPLSLEENREERAEIHMKRESSLEATAVPSQQNLLSAL  566 (1017)
Q Consensus       487 ~~~~~~k~~v~~~~~~~~~k~s~~~~~~p~~~~~~~~~~~~~~~~s~e~~~~~~~~~~~~~~~~~~~~a~~~qq~~~~~~  566 (1017)
                      +                  +      ..+...+.+.+--+  .-++.            .........+....-+....+
T Consensus       339 ~------------------~------~~~~~~ll~q~~~~--a~L~~------------~~~~~~~~~~~a~~~D~~~~i  380 (811)
T KOG1929|consen  339 D------------------H------ESPDKDLLRQYHGK--AYLFP------------SSARSYQKIRSAVPLDSLPDI  380 (811)
T ss_pred             C------------------c------cccchhHHhhcCCc--eeecC------------cccccccccccccccCCCccc
Confidence            0                  0      00000011110000  00000            000000000000000000000


Q ss_pred             cccccccccccch--hhhhhhccccccCCCCCcEEEEcCCCChhhHHHHHHHHHcC-CCEEEecCCCCceEEEEeeCCCc
Q 001761          567 SDENKTQLRTKED--FRVQSLQNMKLSTVFRGKIFRFSNSFPEDRRAEIVQWVNQG-RGEVVNDDAKQNVHFTIECHGVI  643 (1017)
Q Consensus       567 ~~~~~~~~~~~~~--s~~~~~~~~~~~~iF~G~~F~i~~~f~~~~~~~l~~~I~~~-GG~Vv~~~~~~~td~iI~~~~~~  643 (1017)
                      ...++.+......  +............+|-...+-+   |+.+   .+...+..+ +-...-. .....++++..+...
T Consensus       381 s~i~e~~~~~~tp~~~~~~~~~~~~~~~~~v~s~~~~---~~~e---~i~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~  453 (811)
T KOG1929|consen  381 SSINENQDSLGTPSFSESRELGAKLLKPVDVPSVKPF---FNTE---KIESSSFENELLHHLLL-PSTFLDVTLTEFAGV  453 (811)
T ss_pred             ccccCCCCccccccccchhhhhhhhcccccccccccc---cchh---hhccccccccchhcccc-ccccccceeeccccc
Confidence            0000000000000  0000000011111222111100   1111   111111110 0000000 112234444322110


Q ss_pred             cccccCCCCcEEeHHHHHHHHhhCcccCCCCCccCCCCCCCCCCCCCCCeEEEEeccChhhHHHHHHHHHHcCcEEeccc
Q 001761          644 PKSADASETTYVSSHWIRSCLEDGCLLDVGSHILYSPLHCQTPLPGFERFRFCVSQYEEKDRVLLRNLCFVLGAKFMEKL  723 (1017)
Q Consensus       644 ~~~~~~~~~~vVt~~Wl~~Cl~~~~ll~~~~~~l~~Pl~~~~pi~~f~g~~i~~Sg~~~~er~~l~~li~~lGg~~~~~l  723 (1017)
                         .....+.+|+..|...|+......+   ..+++|+|+..+..+|+++.|++++..+.++..+..++..+||.....|
T Consensus       454 ---e~~~~~k~v~~~~~v~~~~~~~~~~---~~~~~~vp~~~l~~~~e~~~~~~s~~~~~~~e~ln~~~~~~gas~~~~f  527 (811)
T KOG1929|consen  454 ---EVKHLLKNVTNPFSVNCILDLSSST---EDNLRPVPAAALSQPFENLTISNSQSAEAEREKLNNLANDLGASNVKTF  527 (811)
T ss_pred             ---eeehhcccccchhHHHHHHHhhcCc---hhhcCcchhhcccccccCceEEeeechHHHHHHHhHhhhhcccccccee
Confidence               0112334899999999999887777   2367899999999999999999999999999999999999999999999


Q ss_pred             cCcceEEEEccCChHHHHHHHcCCCceeChhHHHHHHHhCccCCCCCcCCCCCCccccccCcccccCCCCccccccCCCC
Q 001761          724 TKKVTHLLCKFAGGLKYEAACKWGIPSITSEWIYECVRQNEVVSLDHFSPKEVTTHDREAGLCTVSQFPMQSVQMSSADE  803 (1017)
Q Consensus       724 ~~~~THLI~~~~~g~Ky~~A~~w~I~IV~~~WL~dc~~~g~~l~e~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  803 (1017)
                      .++.|||||....|.||+.|.+|+||||+++||++|.++++..+.+.|+..+.+.+++..+.    +-..+...+....-
T Consensus       528 ~r~~~~l~~~~~k~s~~~~~~kw~ip~vT~~wL~e~~rq~~~~~~e~~l~~~st~~e~~~~~----~~~~~~~P~~k~~t  603 (811)
T KOG1929|consen  528 TRKSTTLLTTSAKGSKYEIAGKWSIPIVTPDWLYECVRQNKGERNEGFLNGNSTAKERPISP----SIRFAVVPGKKPDT  603 (811)
T ss_pred             eecccEEeccccccchhhhccccCCCccChhHHHhhccccCcccceeeccccccccccCccc----ccccccCCCCCcce
Confidence            99999999999999999999999999999999999999999999999999998888877652    11111111111111


Q ss_pred             CCCCCCCCCCCCCCCCcccccccccccc---cccchhhhccccccccccccccccCCCCCCccccCCC--CCCCCCCCCC
Q 001761          804 PSQFINPLGGLQSSSPQTMVHKIDDITR---SDNLRDEANQTSAHNKRARISEDEDHDTLPGVHLKDP--HRSTNYNGDS  878 (1017)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  878 (1017)
                      .+-...+..+..  .++.+++.++ +..   -.-+..-..+..+.+|.+.+....+.-....+-+...  +-.++.++..
T Consensus       604 ~s~sv~~~~~~~--~~~s~~~v~~-~g~~~~~e~h~~~d~~~~~~sk~~~~~~~~d~~~~~~~le~~~~~~ps~~~~~v~  680 (811)
T KOG1929|consen  604 VSKSVVHKEDTN--KPKSVATVSG-KGSGSVYEEHLLLDTEVKFDSKIAKTPPGGDLRDVSDYLELPLFDRPSHDLSRVV  680 (811)
T ss_pred             eecceecccccC--CCcccccccc-cCCCccccccccccchhhhhhhhhcCCCcccccccccceecccccCcCCChhhcc
Confidence            222222111111  1222333222 211   0112333445566778888877766655555444443  2233434444


Q ss_pred             CcccCCCCCCCCchHHHHHHHHHhhhccccC--CCCcccc-cccccccCCCCcccCcCCCCCcccccc---ccccccc--
Q 001761          879 MSKDNGEVPHIGSDVAAVIEDLVEQTSKVQD--LKSPERS-ECDKSLFPSDCSVLGQNHTDFNSVIGL---SRQWSNR--  950 (1017)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--  950 (1017)
                      .--++...+...+++++.  .+.+|.+|+|+  ...|.|. .|+...|.-     .|+..+.+.+-|.   ++||++.  
T Consensus       681 ~~~~~~a~~~~~r~~~~~--~~s~~~~k~q~t~~~~~~r~~~~e~~~~~~-----~~~~~~~~~~~g~~~~~~~~~~~~~  753 (811)
T KOG1929|consen  681 LQQYDLASSQRKRTALDG--CVSEQVPKKQPTAISNPERIQRTEKVSHLN-----DRYAPGIDDKRGASLEEPHWRLTRN  753 (811)
T ss_pred             ceeeeeccccccchhhhh--hhhhhcCCcCcccccCccccccccccchhh-----cccCCCcccccchhhhchhhhcccc
Confidence            445777788888888888  89999999998  7777763 233222222     4666666666666   9999999  


Q ss_pred             ---ccccCCCCCCCCCCCCCCcccCCCCcccccceeeeecccccchhHHHHhhhhhH
Q 001761          951 ---TLKKNDIQNPFNSKGVRSGIYEPFSETQTESQVVSYEEDLSGRQKIIDRAKSEA 1004 (1017)
Q Consensus       951 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1017)
                         .+|.+|++.|  .+.+..-.|.+|++++++|||+||+++.+|+++.+++.|+..
T Consensus       754 ~~~~~~~~d~se~--~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~r~~~  808 (811)
T KOG1929|consen  754 QTKDHKPDDISEP--DGKKGEERVETNRLQTPPSNVAKKSKKEDGAKANLTVKRDIW  808 (811)
T ss_pred             ccccCCccccccC--cchhhhhhccCcccccCCccccCCCcccchHHHHhhhhcccc
Confidence               8899999999  777766669999999999999999999999999999999754

>KOG1929 consensus Nucleotide excision repair factor NEF2, RAD4/CUT5 component [Replication, recombination and repair] Back     alignment and domain information
>KOG3524 consensus Predicted guanine nucleotide exchange factor (PEBBLE) [Signal transduction mechanisms] Back     alignment and domain information
>PF12738 PTCB-BRCT: twin BRCT domain; PDB: 3PA6_A 3KTF_C 2WT8_C 3EF1_A 3EF0_A Back     alignment and domain information
>PF12738 PTCB-BRCT: twin BRCT domain; PDB: 3PA6_A 3KTF_C 2WT8_C 3EF1_A 3EF0_A Back     alignment and domain information
>PF00533 BRCT: BRCA1 C Terminus (BRCT) domain; InterPro: IPR001357 The BRCT domain (after the C_terminal domain of a breast cancer susceptibility protein) is found predominantly in proteins involved in cell cycle checkpoint functions responsive to DNA damage [], for example as found in the breast cancer DNA-repair protein BRCA1 Back     alignment and domain information
>PF00533 BRCT: BRCA1 C Terminus (BRCT) domain; InterPro: IPR001357 The BRCT domain (after the C_terminal domain of a breast cancer susceptibility protein) is found predominantly in proteins involved in cell cycle checkpoint functions responsive to DNA damage [], for example as found in the breast cancer DNA-repair protein BRCA1 Back     alignment and domain information
>KOG3226 consensus DNA repair protein [Replication, recombination and repair] Back     alignment and domain information
>smart00292 BRCT breast cancer carboxy-terminal domain Back     alignment and domain information
>cd00027 BRCT Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain Back     alignment and domain information
>smart00292 BRCT breast cancer carboxy-terminal domain Back     alignment and domain information
>cd00027 BRCT Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain Back     alignment and domain information
>KOG3524 consensus Predicted guanine nucleotide exchange factor (PEBBLE) [Signal transduction mechanisms] Back     alignment and domain information
>KOG3226 consensus DNA repair protein [Replication, recombination and repair] Back     alignment and domain information
>KOG0966 consensus ATP-dependent DNA ligase IV [Replication, recombination and repair] Back     alignment and domain information
>KOG4362 consensus Transcriptional regulator BRCA1 [Replication, recombination and repair; Transcription] Back     alignment and domain information
>KOG0966 consensus ATP-dependent DNA ligase IV [Replication, recombination and repair] Back     alignment and domain information
>PLN03122 Poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
>KOG3548 consensus DNA damage checkpoint protein RHP9/CRB2/53BP1 [Replication, recombination and repair] Back     alignment and domain information
>PLN03122 Poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
>PLN03123 poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
>PLN03123 poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
>KOG4362 consensus Transcriptional regulator BRCA1 [Replication, recombination and repair; Transcription] Back     alignment and domain information
>KOG3548 consensus DNA damage checkpoint protein RHP9/CRB2/53BP1 [Replication, recombination and repair] Back     alignment and domain information
>KOG2043 consensus Signaling protein SWIFT and related BRCT domain proteins [Transcription; Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Replication, recombination and repair] Back     alignment and domain information
>PRK14350 ligA NAD-dependent DNA ligase LigA; Provisional Back     alignment and domain information
>PRK06195 DNA polymerase III subunit epsilon; Validated Back     alignment and domain information
>PRK06063 DNA polymerase III subunit epsilon; Provisional Back     alignment and domain information
>COG0272 Lig NAD-dependent DNA ligase (contains BRCT domain type II) [DNA replication, recombination, and repair] Back     alignment and domain information
>PRK07956 ligA NAD-dependent DNA ligase LigA; Validated Back     alignment and domain information
>PRK14351 ligA NAD-dependent DNA ligase LigA; Provisional Back     alignment and domain information
>PRK14350 ligA NAD-dependent DNA ligase LigA; Provisional Back     alignment and domain information
>TIGR00575 dnlj DNA ligase, NAD-dependent Back     alignment and domain information
>PRK06063 DNA polymerase III subunit epsilon; Provisional Back     alignment and domain information
>PRK06195 DNA polymerase III subunit epsilon; Validated Back     alignment and domain information
>PRK14351 ligA NAD-dependent DNA ligase LigA; Provisional Back     alignment and domain information
>PRK07956 ligA NAD-dependent DNA ligase LigA; Validated Back     alignment and domain information
>COG0272 Lig NAD-dependent DNA ligase (contains BRCT domain type II) [DNA replication, recombination, and repair] Back     alignment and domain information
>KOG2481 consensus Protein required for normal rRNA processing [RNA processing and modification] Back     alignment and domain information
>TIGR00575 dnlj DNA ligase, NAD-dependent Back     alignment and domain information
>KOG2481 consensus Protein required for normal rRNA processing [RNA processing and modification] Back     alignment and domain information
>COG5163 NOP7 Protein required for biogenesis of the 60S ribosomal subunit [Translation, ribosomal structure and biogenesis] Back     alignment and domain information
>COG5275 BRCT domain type II [General function prediction only] Back     alignment and domain information
>KOG0323 consensus TFIIF-interacting CTD phosphatases, including NLI-interacting factor [Transcription] Back     alignment and domain information
>COG5163 NOP7 Protein required for biogenesis of the 60S ribosomal subunit [Translation, ribosomal structure and biogenesis] Back     alignment and domain information
>KOG0323 consensus TFIIF-interacting CTD phosphatases, including NLI-interacting factor [Transcription] Back     alignment and domain information
>KOG2043 consensus Signaling protein SWIFT and related BRCT domain proteins [Transcription; Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Replication, recombination and repair] Back     alignment and domain information
>COG5275 BRCT domain type II [General function prediction only] Back     alignment and domain information
>KOG2093 consensus Translesion DNA polymerase - REV1 deoxycytidyl transferase [Replication, recombination and repair] Back     alignment and domain information
>PRK05601 DNA polymerase III subunit epsilon; Validated Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

Original result of BLAST against Protein Data Bank

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1017
3olc_X298 Crystal Structure Of The N-Terminal Region Of Topbp 2e-22
2xnk_A292 Structure And Function Of The Rad9-Binding Region O 2e-22
2xnh_A287 Structure And Function Of The Rad9-Binding Region O 2e-22
1wf6_A132 The Third Brca1 C-Terminus (Brct) Domain Of Similar 5e-05
2d8m_A129 Solution Structure Of The First Brct Domain Of Dna- 3e-04
>pdb|3OLC|X Chain X, Crystal Structure Of The N-Terminal Region Of Topbp1 Length = 298 Back     alignment and structure 
Iteration: 1

 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 116/232 (50%), Gaps = 24/232 (10%)
Query: 63  FEDLRAKGCNLLGPQCVLSCAKENRALPKQGFTCC-LAMDGVKVIASGFDVDEKFKIEKL 121
           F+ L+  GC ++GPQ V+ C    R +P+            V +  +  + +++ ++ K 
Sbjct: 68  FDHLKKLGCRIVGPQVVIFCXHHQRCVPRAEHPVYNXVXSDVTISCTSLEKEKREEVHKY 127
Query: 122 VTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCW---NEHRV-- 176
           V   GG +     + V+ +I   V + KY  A N LKKPI+  +W+   W    E ++  
Sbjct: 128 VQXXGGRVYRDLNVSVTHLIAGEVGSKKYLVAAN-LKKPILLPSWIKTLWEKSQEKKITR 186
Query: 177 ---VPQESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPEL-TKKCTHLICDIS 232
              +  E +K   F G +ICVT +   +RKE+++L V++GG+Y  +L   +CTHLI    
Sbjct: 187 YTDINXEDFKCPIFLGCIICVTGLCGLDRKEVQQLTVKHGGQYXGQLKXNECTHLIVQ-- 244
Query: 233 FTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQ 284
                      P+G K++ AKRW ++H +  +WF  S+ +  C +E  Y  +
Sbjct: 245 ----------EPKGQKYECAKRW-NVHCVTTQWFFDSIEKGFCQDESIYKTE 285
>pdb|2XNK|A Chain A, Structure And Function Of The Rad9-Binding Region Of The Dna Damage Checkpoint Adaptor Topbp1 Length = 292 Back     alignment and structure
>pdb|2XNH|A Chain A, Structure And Function Of The Rad9-Binding Region Of The Dna Damage Checkpoint Adaptor Topbp1 Length = 287 Back     alignment and structure
>pdb|1WF6|A Chain A, The Third Brca1 C-Terminus (Brct) Domain Of Similar To S.Pombe Rad4+CUT5+ PRODUCT Length = 132 Back     alignment and structure
>pdb|2D8M|A Chain A, Solution Structure Of The First Brct Domain Of Dna-Repair Protein Xrcc1 Length = 129 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

Original result of RPS-BLAST against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1017
3olc_X298 DNA topoisomerase 2-binding protein 1; BRCT domain 4e-54
3olc_X298 DNA topoisomerase 2-binding protein 1; BRCT domain 4e-23
3olc_X298 DNA topoisomerase 2-binding protein 1; BRCT domain 1e-18
3olc_X298 DNA topoisomerase 2-binding protein 1; BRCT domain 7e-05
3l46_A112 Protein ECT2; alternative splicing, guanine-nucleo 9e-29
3l46_A112 Protein ECT2; alternative splicing, guanine-nucleo 6e-18
3l46_A112 Protein ECT2; alternative splicing, guanine-nucleo 1e-09
3l46_A112 Protein ECT2; alternative splicing, guanine-nucleo 1e-06
2cou_A109 ECT2 protein; BRCT domain, RHO GTPase, structural 5e-28
2cou_A109 ECT2 protein; BRCT domain, RHO GTPase, structural 2e-16
2cou_A109 ECT2 protein; BRCT domain, RHO GTPase, structural 1e-08
2cou_A109 ECT2 protein; BRCT domain, RHO GTPase, structural 1e-06
2d8m_A129 DNA-repair protein XRCC1; parallel beta-sheet, DNA 2e-23
2d8m_A129 DNA-repair protein XRCC1; parallel beta-sheet, DNA 9e-23
2d8m_A129 DNA-repair protein XRCC1; parallel beta-sheet, DNA 1e-12
2d8m_A129 DNA-repair protein XRCC1; parallel beta-sheet, DNA 5e-06
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 6e-21
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 1e-08
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 2e-07
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 2e-06
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 1e-04
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 1e-04
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 2e-04
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 3e-04
1l0b_A229 BRCA1; TANDEM-BRCT, three-helix bundle, unknown fu 1e-20
1l0b_A229 BRCA1; TANDEM-BRCT, three-helix bundle, unknown fu 2e-13
1l0b_A229 BRCA1; TANDEM-BRCT, three-helix bundle, unknown fu 6e-12
1l0b_A229 BRCA1; TANDEM-BRCT, three-helix bundle, unknown fu 2e-07
1l0b_A229 BRCA1; TANDEM-BRCT, three-helix bundle, unknown fu 3e-05
3l3e_A107 DNA topoisomerase 2-binding protein 1; BRCT domain 1e-20
3l3e_A107 DNA topoisomerase 2-binding protein 1; BRCT domain 2e-16
3l3e_A107 DNA topoisomerase 2-binding protein 1; BRCT domain 4e-10
3l3e_A107 DNA topoisomerase 2-binding protein 1; BRCT domain 5e-10
1wf6_A132 Similar to S.pombe -RAD4+/CUT5+product (A40727); B 7e-19
1wf6_A132 Similar to S.pombe -RAD4+/CUT5+product (A40727); B 9e-18
1wf6_A132 Similar to S.pombe -RAD4+/CUT5+product (A40727); B 3e-13
1wf6_A132 Similar to S.pombe -RAD4+/CUT5+product (A40727); B 7e-13
1wf6_A132 Similar to S.pombe -RAD4+/CUT5+product (A40727); B 2e-04
1t15_A214 Breast cancer type 1 susceptibility protein; prote 8e-19
1t15_A214 Breast cancer type 1 susceptibility protein; prote 7e-15
1t15_A214 Breast cancer type 1 susceptibility protein; prote 7e-12
1t15_A214 Breast cancer type 1 susceptibility protein; prote 2e-08
1t15_A214 Breast cancer type 1 susceptibility protein; prote 1e-05
1t15_A214 Breast cancer type 1 susceptibility protein; prote 3e-04
2nte_A210 BARD-1, BRCA1-associated ring domain protein 1; BR 8e-18
2nte_A210 BARD-1, BRCA1-associated ring domain protein 1; BR 8e-15
2nte_A210 BARD-1, BRCA1-associated ring domain protein 1; BR 1e-11
2nte_A210 BARD-1, BRCA1-associated ring domain protein 1; BR 7e-06
2nte_A210 BARD-1, BRCA1-associated ring domain protein 1; BR 6e-04
3pc6_A104 DNA repair protein XRCC1; BRCT domain, protein:pro 5e-17
3pc6_A104 DNA repair protein XRCC1; BRCT domain, protein:pro 9e-17
3pc6_A104 DNA repair protein XRCC1; BRCT domain, protein:pro 3e-08
3pc6_A104 DNA repair protein XRCC1; BRCT domain, protein:pro 9e-08
3pc6_A104 DNA repair protein XRCC1; BRCT domain, protein:pro 4e-07
3pa6_A107 Microcephalin; BRCT domain, cell cycle; HET: MSE; 1e-16
3pa6_A107 Microcephalin; BRCT domain, cell cycle; HET: MSE; 1e-08
3pa6_A107 Microcephalin; BRCT domain, cell cycle; HET: MSE; 4e-08
2ebw_A97 DNA repair protein REV1; A/B/A 3 layers, parallel 2e-15
2ebw_A97 DNA repair protein REV1; A/B/A 3 layers, parallel 7e-11
2ebw_A97 DNA repair protein REV1; A/B/A 3 layers, parallel 7e-09
2ebw_A97 DNA repair protein REV1; A/B/A 3 layers, parallel 5e-08
2ebw_A97 DNA repair protein REV1; A/B/A 3 layers, parallel 6e-07
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-14
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-10
3sqd_A219 PAX-interacting protein 1; tandem BRCT domains, ce 8e-14
3sqd_A219 PAX-interacting protein 1; tandem BRCT domains, ce 2e-11
3sqd_A219 PAX-interacting protein 1; tandem BRCT domains, ce 3e-08
3sqd_A219 PAX-interacting protein 1; tandem BRCT domains, ce 3e-05
1z56_C264 DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA 2e-12
1z56_C264 DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA 4e-08
3u3z_A199 Microcephalin; DNA repair, cell cycle regulation, 6e-12
3u3z_A199 Microcephalin; DNA repair, cell cycle regulation, 3e-10
3u3z_A199 Microcephalin; DNA repair, cell cycle regulation, 3e-07
3u3z_A199 Microcephalin; DNA repair, cell cycle regulation, 5e-06
2etx_A209 Mediator of DNA damage checkpoint protein 1; tande 6e-12
2etx_A209 Mediator of DNA damage checkpoint protein 1; tande 3e-06
2etx_A209 Mediator of DNA damage checkpoint protein 1; tande 3e-05
2etx_A209 Mediator of DNA damage checkpoint protein 1; tande 7e-05
3al2_A235 DNA topoisomerase 2-binding protein 1; BRCT domain 2e-11
3al2_A235 DNA topoisomerase 2-binding protein 1; BRCT domain 2e-09
3al2_A235 DNA topoisomerase 2-binding protein 1; BRCT domain 2e-08
3al2_A235 DNA topoisomerase 2-binding protein 1; BRCT domain 3e-05
1kzy_C259 Tumor suppressor P53-binding protein 1; tandem-BRC 7e-10
1kzy_C259 Tumor suppressor P53-binding protein 1; tandem-BRC 1e-09
1kzy_C259 Tumor suppressor P53-binding protein 1; tandem-BRC 1e-04
1kzy_C259 Tumor suppressor P53-binding protein 1; tandem-BRC 8e-04
3l41_A220 BRCT-containing protein 1; BRC1, BRCT domain, tand 1e-08
3l41_A220 BRCT-containing protein 1; BRC1, BRCT domain, tand 2e-08
3l41_A220 BRCT-containing protein 1; BRC1, BRCT domain, tand 2e-07
3l41_A220 BRCT-containing protein 1; BRC1, BRCT domain, tand 3e-04
2jw5_A106 DNA polymerase lambda; BRCT domain, family X polym 1e-08
2jw5_A106 DNA polymerase lambda; BRCT domain, family X polym 8e-07
2jw5_A106 DNA polymerase lambda; BRCT domain, family X polym 3e-04
3ef1_A442 RNA polymerase II subunit A C-terminal domain phos 9e-07
3ef1_A442 RNA polymerase II subunit A C-terminal domain phos 3e-05
3ef0_A372 RNA polymerase II subunit A C-terminal domain phos 1e-06
3ef0_A372 RNA polymerase II subunit A C-terminal domain phos 8e-06
2cok_A113 Poly [ADP-ribose] polymerase-1; BRCT domain, DNA r 5e-04
2vxb_A241 DNA repair protein RHP9; BRCT, nucleus, cell cycle 9e-04
>3olc_X DNA topoisomerase 2-binding protein 1; BRCT domain, DNA repair, RAD9, DNA binding protein; HET: DNA; 2.40A {Homo sapiens} PDB: 2xnk_A* 2xnh_A* Length = 298 Back     alignment and structure
 Score =  189 bits (482), Expect = 4e-54
 Identities = 75/300 (25%), Positives = 133/300 (44%), Gaps = 30/300 (10%)

Query: 2   MKPKPFKEAKVYMSRNLVAPEIFDALLDALKLNGAEVELCCDPSRTG------PNDFHVI 55
           M     +   V   ++    + F   L+++K   +E  L                  ++ 
Sbjct: 1   MSRNDKEPFFVKFLKSSDNSKCFFKALESIKEFQSEEYLQIITEEEALKIKENDRSLYIC 60

Query: 56  SSSDHEKFEDLRAKGCNLLGPQCVLSCAKENRALPKQGFT-CCLAMDGVKVIASGFDVDE 114
                  F+ L+  GC ++GPQ V+ C    R +P+       + M  V +  +  + ++
Sbjct: 61  DPFSGVVFDHLKKLGCRIVGPQVVIFCMHHQRCVPRAEHPVYNMVMSDVTISCTSLEKEK 120

Query: 115 KFKIEKLVTAMGGVLQTKATLDVSFVIVKNVLAAKYKWALNILKKPIVTVNWLYQCWNEH 174
           + ++ K V  MGG +     + V+ +I   V + KY  A N LKKPI+  +W+   W + 
Sbjct: 121 REEVHKYVQMMGGRVYRDLNVSVTHLIAGEVGSKKYLVAAN-LKKPILLPSWIKTLWEKS 179

Query: 175 RVVP--------QESYKVLPFSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTK-KCT 225
           +            E +K   F G +ICVT +   +RKE+++L V++GG+Y  +L   +CT
Sbjct: 180 QEKKITRYTDINMEDFKCPIFLGCIICVTGLCGLDRKEVQQLTVKHGGQYMGQLKMNECT 239

Query: 226 HLICDISFTIYFLNFPYTPEGDKFKVAKRWGHIHIINRKWFDQSMARRACLNEESYTVQD 285
           HLI               P+G K++ AKRW  +H +  +WF  S+ +  C +E  Y  + 
Sbjct: 240 HLIVQ------------EPKGQKYECAKRWN-VHCVTTQWFFDSIEKGFCQDESIYKTEP 286
>3olc_X DNA topoisomerase 2-binding protein 1; BRCT domain, DNA repair, RAD9, DNA binding protein; HET: DNA; 2.40A {Homo sapiens} PDB: 2xnk_A* 2xnh_A* Length = 298 Back     alignment and structure
>3olc_X DNA topoisomerase 2-binding protein 1; BRCT domain, DNA repair, RAD9, DNA binding protein; HET: DNA; 2.40A {Homo sapiens} PDB: 2xnk_A* 2xnh_A* Length = 298 Back     alignment and structure
>3olc_X DNA topoisomerase 2-binding protein 1; BRCT domain, DNA repair, RAD9, DNA binding protein; HET: DNA; 2.40A {Homo sapiens} PDB: 2xnk_A* 2xnh_A* Length = 298 Back     alignment and structure
>3l46_A Protein ECT2; alternative splicing, guanine-nucleotide releasing factor, phosphoprotein, polymorphism, proto-oncogene, structural genomics; 1.48A {Homo sapiens} Length = 112 Back     alignment and structure
>3l46_A Protein ECT2; alternative splicing, guanine-nucleotide releasing factor, phosphoprotein, polymorphism, proto-oncogene, structural genomics; 1.48A {Homo sapiens} Length = 112 Back     alignment and structure
>3l46_A Protein ECT2; alternative splicing, guanine-nucleotide releasing factor, phosphoprotein, polymorphism, proto-oncogene, structural genomics; 1.48A {Homo sapiens} Length = 112 Back     alignment and structure
>3l46_A Protein ECT2; alternative splicing, guanine-nucleotide releasing factor, phosphoprotein, polymorphism, proto-oncogene, structural genomics; 1.48A {Homo sapiens} Length = 112 Back     alignment and structure
>2cou_A ECT2 protein; BRCT domain, RHO GTPase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 109 Back     alignment and structure
>2cou_A ECT2 protein; BRCT domain, RHO GTPase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 109 Back     alignment and structure
>2cou_A ECT2 protein; BRCT domain, RHO GTPase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 109 Back     alignment and structure
>2cou_A ECT2 protein; BRCT domain, RHO GTPase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 109 Back     alignment and structure
>2d8m_A DNA-repair protein XRCC1; parallel beta-sheet, DNA ligase III, poly(ADP-ribose) polymerase-1, DNA polymerase beta, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 129 Back     alignment and structure
>2d8m_A DNA-repair protein XRCC1; parallel beta-sheet, DNA ligase III, poly(ADP-ribose) polymerase-1, DNA polymerase beta, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 129 Back     alignment and structure
>2d8m_A DNA-repair protein XRCC1; parallel beta-sheet, DNA ligase III, poly(ADP-ribose) polymerase-1, DNA polymerase beta, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 129 Back     alignment and structure
>2d8m_A DNA-repair protein XRCC1; parallel beta-sheet, DNA ligase III, poly(ADP-ribose) polymerase-1, DNA polymerase beta, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 129 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>1l0b_A BRCA1; TANDEM-BRCT, three-helix bundle, unknown function; 2.30A {Rattus norvegicus} SCOP: c.15.1.3 c.15.1.3 Length = 229 Back     alignment and structure
>1l0b_A BRCA1; TANDEM-BRCT, three-helix bundle, unknown function; 2.30A {Rattus norvegicus} SCOP: c.15.1.3 c.15.1.3 Length = 229 Back     alignment and structure
>1l0b_A BRCA1; TANDEM-BRCT, three-helix bundle, unknown function; 2.30A {Rattus norvegicus} SCOP: c.15.1.3 c.15.1.3 Length = 229 Back     alignment and structure
>1l0b_A BRCA1; TANDEM-BRCT, three-helix bundle, unknown function; 2.30A {Rattus norvegicus} SCOP: c.15.1.3 c.15.1.3 Length = 229 Back     alignment and structure
>1l0b_A BRCA1; TANDEM-BRCT, three-helix bundle, unknown function; 2.30A {Rattus norvegicus} SCOP: c.15.1.3 c.15.1.3 Length = 229 Back     alignment and structure
>1wf6_A Similar to S.pombe -RAD4+/CUT5+product (A40727); BRCT, topoisomerase II binding protein, checkpoint; NMR {Homo sapiens} SCOP: c.15.1.5 Length = 132 Back     alignment and structure
>1wf6_A Similar to S.pombe -RAD4+/CUT5+product (A40727); BRCT, topoisomerase II binding protein, checkpoint; NMR {Homo sapiens} SCOP: c.15.1.5 Length = 132 Back     alignment and structure
>1wf6_A Similar to S.pombe -RAD4+/CUT5+product (A40727); BRCT, topoisomerase II binding protein, checkpoint; NMR {Homo sapiens} SCOP: c.15.1.5 Length = 132 Back     alignment and structure
>1wf6_A Similar to S.pombe -RAD4+/CUT5+product (A40727); BRCT, topoisomerase II binding protein, checkpoint; NMR {Homo sapiens} SCOP: c.15.1.5 Length = 132 Back     alignment and structure
>1wf6_A Similar to S.pombe -RAD4+/CUT5+product (A40727); BRCT, topoisomerase II binding protein, checkpoint; NMR {Homo sapiens} SCOP: c.15.1.5 Length = 132 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Length = 214 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Length = 214 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Length = 214 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Length = 214 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Length = 214 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Length = 214 Back     alignment and structure
>2nte_A BARD-1, BRCA1-associated ring domain protein 1; BRCT, ring finger, zinc-binding protein, ubiquitin LI antitumor protein; 1.90A {Homo sapiens} PDB: 3fa2_A 2r1z_A Length = 210 Back     alignment and structure
>2nte_A BARD-1, BRCA1-associated ring domain protein 1; BRCT, ring finger, zinc-binding protein, ubiquitin LI antitumor protein; 1.90A {Homo sapiens} PDB: 3fa2_A 2r1z_A Length = 210 Back     alignment and structure
>2nte_A BARD-1, BRCA1-associated ring domain protein 1; BRCT, ring finger, zinc-binding protein, ubiquitin LI antitumor protein; 1.90A {Homo sapiens} PDB: 3fa2_A 2r1z_A Length = 210 Back     alignment and structure
>2nte_A BARD-1, BRCA1-associated ring domain protein 1; BRCT, ring finger, zinc-binding protein, ubiquitin LI antitumor protein; 1.90A {Homo sapiens} PDB: 3fa2_A 2r1z_A Length = 210 Back     alignment and structure
>2nte_A BARD-1, BRCA1-associated ring domain protein 1; BRCT, ring finger, zinc-binding protein, ubiquitin LI antitumor protein; 1.90A {Homo sapiens} PDB: 3fa2_A 2r1z_A Length = 210 Back     alignment and structure
>3pc6_A DNA repair protein XRCC1; BRCT domain, protein:protein interactions, DNA L III-alpha BRCT2 domain, DNA binding protein; HET: DNA; 1.90A {Mus musculus} PDB: 3pc8_A* 3qvg_B* 1cdz_A Length = 104 Back     alignment and structure
>3pc6_A DNA repair protein XRCC1; BRCT domain, protein:protein interactions, DNA L III-alpha BRCT2 domain, DNA binding protein; HET: DNA; 1.90A {Mus musculus} PDB: 3pc8_A* 3qvg_B* 1cdz_A Length = 104 Back     alignment and structure
>3pc6_A DNA repair protein XRCC1; BRCT domain, protein:protein interactions, DNA L III-alpha BRCT2 domain, DNA binding protein; HET: DNA; 1.90A {Mus musculus} PDB: 3pc8_A* 3qvg_B* 1cdz_A Length = 104 Back     alignment and structure
>3pc6_A DNA repair protein XRCC1; BRCT domain, protein:protein interactions, DNA L III-alpha BRCT2 domain, DNA binding protein; HET: DNA; 1.90A {Mus musculus} PDB: 3pc8_A* 3qvg_B* 1cdz_A Length = 104 Back     alignment and structure
>3pc6_A DNA repair protein XRCC1; BRCT domain, protein:protein interactions, DNA L III-alpha BRCT2 domain, DNA binding protein; HET: DNA; 1.90A {Mus musculus} PDB: 3pc8_A* 3qvg_B* 1cdz_A Length = 104 Back     alignment and structure
>3pa6_A Microcephalin; BRCT domain, cell cycle; HET: MSE; 1.50A {Homo sapiens} PDB: 3ktf_A* 2wt8_A* Length = 107 Back     alignment and structure
>3pa6_A Microcephalin; BRCT domain, cell cycle; HET: MSE; 1.50A {Homo sapiens} PDB: 3ktf_A* 2wt8_A* Length = 107 Back     alignment and structure
>3pa6_A Microcephalin; BRCT domain, cell cycle; HET: MSE; 1.50A {Homo sapiens} PDB: 3ktf_A* 2wt8_A* Length = 107 Back     alignment and structure
>2ebw_A DNA repair protein REV1; A/B/A 3 layers, parallel beta-sheet, DNA replication, translession synthesis, TLS, DNA polymerase zeta, PCNA; HET: DNA; NMR {Homo sapiens} Length = 97 Back     alignment and structure
>2ebw_A DNA repair protein REV1; A/B/A 3 layers, parallel beta-sheet, DNA replication, translession synthesis, TLS, DNA polymerase zeta, PCNA; HET: DNA; NMR {Homo sapiens} Length = 97 Back     alignment and structure
>2ebw_A DNA repair protein REV1; A/B/A 3 layers, parallel beta-sheet, DNA replication, translession synthesis, TLS, DNA polymerase zeta, PCNA; HET: DNA; NMR {Homo sapiens} Length = 97 Back     alignment and structure
>2ebw_A DNA repair protein REV1; A/B/A 3 layers, parallel beta-sheet, DNA replication, translession synthesis, TLS, DNA polymerase zeta, PCNA; HET: DNA; NMR {Homo sapiens} Length = 97 Back     alignment and structure
>2ebw_A DNA repair protein REV1; A/B/A 3 layers, parallel beta-sheet, DNA replication, translession synthesis, TLS, DNA polymerase zeta, PCNA; HET: DNA; NMR {Homo sapiens} Length = 97 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>3sqd_A PAX-interacting protein 1; tandem BRCT domains, cell cycle; HET: SEP; 2.15A {Homo sapiens} Length = 219 Back     alignment and structure
>3sqd_A PAX-interacting protein 1; tandem BRCT domains, cell cycle; HET: SEP; 2.15A {Homo sapiens} Length = 219 Back     alignment and structure
>3sqd_A PAX-interacting protein 1; tandem BRCT domains, cell cycle; HET: SEP; 2.15A {Homo sapiens} Length = 219 Back     alignment and structure
>3sqd_A PAX-interacting protein 1; tandem BRCT domains, cell cycle; HET: SEP; 2.15A {Homo sapiens} Length = 219 Back     alignment and structure
>1z56_C DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA ligase, coiled-coil; HET: DNA; 3.92A {Saccharomyces cerevisiae} Length = 264 Back     alignment and structure
>1z56_C DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA ligase, coiled-coil; HET: DNA; 3.92A {Saccharomyces cerevisiae} Length = 264 Back     alignment and structure
>3u3z_A Microcephalin; DNA repair, cell cycle regulation, cell cycle; HET: SEP PTR; 1.50A {Homo sapiens} PDB: 3szm_A* 3t1n_A* 3sht_A 3shv_A* Length = 199 Back     alignment and structure
>3u3z_A Microcephalin; DNA repair, cell cycle regulation, cell cycle; HET: SEP PTR; 1.50A {Homo sapiens} PDB: 3szm_A* 3t1n_A* 3sht_A 3shv_A* Length = 199 Back     alignment and structure
>3u3z_A Microcephalin; DNA repair, cell cycle regulation, cell cycle; HET: SEP PTR; 1.50A {Homo sapiens} PDB: 3szm_A* 3t1n_A* 3sht_A 3shv_A* Length = 199 Back     alignment and structure
>3u3z_A Microcephalin; DNA repair, cell cycle regulation, cell cycle; HET: SEP PTR; 1.50A {Homo sapiens} PDB: 3szm_A* 3t1n_A* 3sht_A 3shv_A* Length = 199 Back     alignment and structure
>2etx_A Mediator of DNA damage checkpoint protein 1; tandem BRCT domains histone gamma-H2AX, cell cycle; 1.33A {Homo sapiens} PDB: 2azm_A* 3k05_A* 2ado_A Length = 209 Back     alignment and structure
>2etx_A Mediator of DNA damage checkpoint protein 1; tandem BRCT domains histone gamma-H2AX, cell cycle; 1.33A {Homo sapiens} PDB: 2azm_A* 3k05_A* 2ado_A Length = 209 Back     alignment and structure
>2etx_A Mediator of DNA damage checkpoint protein 1; tandem BRCT domains histone gamma-H2AX, cell cycle; 1.33A {Homo sapiens} PDB: 2azm_A* 3k05_A* 2ado_A Length = 209 Back     alignment and structure
>2etx_A Mediator of DNA damage checkpoint protein 1; tandem BRCT domains histone gamma-H2AX, cell cycle; 1.33A {Homo sapiens} PDB: 2azm_A* 3k05_A* 2ado_A Length = 209 Back     alignment and structure
>3al2_A DNA topoisomerase 2-binding protein 1; BRCT domain, protein binding, DNA binding protein; HET: DNA MSE; 2.00A {Homo sapiens} PDB: 3al3_A* Length = 235 Back     alignment and structure
>3al2_A DNA topoisomerase 2-binding protein 1; BRCT domain, protein binding, DNA binding protein; HET: DNA MSE; 2.00A {Homo sapiens} PDB: 3al3_A* Length = 235 Back     alignment and structure
>3al2_A DNA topoisomerase 2-binding protein 1; BRCT domain, protein binding, DNA binding protein; HET: DNA MSE; 2.00A {Homo sapiens} PDB: 3al3_A* Length = 235 Back     alignment and structure
>3al2_A DNA topoisomerase 2-binding protein 1; BRCT domain, protein binding, DNA binding protein; HET: DNA MSE; 2.00A {Homo sapiens} PDB: 3al3_A* Length = 235 Back     alignment and structure
>1kzy_C Tumor suppressor P53-binding protein 1; tandem-BRCT and linker complexed with non-BRCT protein, three-helix bundle, parallel beta sheet; 2.50A {Homo sapiens} SCOP: c.15.1.4 c.15.1.4 PDB: 1gzh_B Length = 259 Back     alignment and structure
>1kzy_C Tumor suppressor P53-binding protein 1; tandem-BRCT and linker complexed with non-BRCT protein, three-helix bundle, parallel beta sheet; 2.50A {Homo sapiens} SCOP: c.15.1.4 c.15.1.4 PDB: 1gzh_B Length = 259 Back     alignment and structure
>1kzy_C Tumor suppressor P53-binding protein 1; tandem-BRCT and linker complexed with non-BRCT protein, three-helix bundle, parallel beta sheet; 2.50A {Homo sapiens} SCOP: c.15.1.4 c.15.1.4 PDB: 1gzh_B Length = 259 Back     alignment and structure
>1kzy_C Tumor suppressor P53-binding protein 1; tandem-BRCT and linker complexed with non-BRCT protein, three-helix bundle, parallel beta sheet; 2.50A {Homo sapiens} SCOP: c.15.1.4 c.15.1.4 PDB: 1gzh_B Length = 259 Back     alignment and structure
>3l41_A BRCT-containing protein 1; BRC1, BRCT domain, tandem BRCT repeat, phosphoserine binding domain, DNA repair, cell division, mitosis; HET: SEP; 1.45A {Schizosaccharomyces pombe} PDB: 3l40_A* Length = 220 Back     alignment and structure
>3l41_A BRCT-containing protein 1; BRC1, BRCT domain, tandem BRCT repeat, phosphoserine binding domain, DNA repair, cell division, mitosis; HET: SEP; 1.45A {Schizosaccharomyces pombe} PDB: 3l40_A* Length = 220 Back     alignment and structure
>3l41_A BRCT-containing protein 1; BRC1, BRCT domain, tandem BRCT repeat, phosphoserine binding domain, DNA repair, cell division, mitosis; HET: SEP; 1.45A {Schizosaccharomyces pombe} PDB: 3l40_A* Length = 220 Back     alignment and structure
>3l41_A BRCT-containing protein 1; BRC1, BRCT domain, tandem BRCT repeat, phosphoserine binding domain, DNA repair, cell division, mitosis; HET: SEP; 1.45A {Schizosaccharomyces pombe} PDB: 3l40_A* Length = 220 Back     alignment and structure
>2jw5_A DNA polymerase lambda; BRCT domain, family X polymerase, nonhomologous END joining (NHEJ), DNA damage, DNA repair, DNA replication, DNA synthesis; HET: DNA; NMR {Homo sapiens} Length = 106 Back     alignment and structure
>2jw5_A DNA polymerase lambda; BRCT domain, family X polymerase, nonhomologous END joining (NHEJ), DNA damage, DNA repair, DNA replication, DNA synthesis; HET: DNA; NMR {Homo sapiens} Length = 106 Back     alignment and structure
>2jw5_A DNA polymerase lambda; BRCT domain, family X polymerase, nonhomologous END joining (NHEJ), DNA damage, DNA repair, DNA replication, DNA synthesis; HET: DNA; NMR {Homo sapiens} Length = 106 Back     alignment and structure
>3ef1_A RNA polymerase II subunit A C-terminal domain phosphatase; CTD, FCPH, BRCT, hydrolase, BEF3, acylphosphate analog, cobalt, magnesium; HET: BFD; 2.15A {Schizosaccharomyces pombe} Length = 442 Back     alignment and structure
>3ef1_A RNA polymerase II subunit A C-terminal domain phosphatase; CTD, FCPH, BRCT, hydrolase, BEF3, acylphosphate analog, cobalt, magnesium; HET: BFD; 2.15A {Schizosaccharomyces pombe} Length = 442 Back     alignment and structure
>3ef0_A RNA polymerase II subunit A C-terminal domain phosphatase; CTD, FCPH, BRCT, hydrolase, ALF4, transition state analog, cobalt, magnesium; 2.10A {Schizosaccharomyces pombe} Length = 372 Back     alignment and structure
>3ef0_A RNA polymerase II subunit A C-terminal domain phosphatase; CTD, FCPH, BRCT, hydrolase, ALF4, transition state analog, cobalt, magnesium; 2.10A {Schizosaccharomyces pombe} Length = 372 Back     alignment and structure
>2cok_A Poly [ADP-ribose] polymerase-1; BRCT domain, DNA repair, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2le0_A Length = 113 Back     alignment and structure
>2vxb_A DNA repair protein RHP9; BRCT, nucleus, cell cycle, DNA damage, DNA replication inhibitor, phosphoprotein, checkpoint signalling; HET: DNA; 2.3A {Schizosaccharomyces pombe} PDB: 2vxc_A* Length = 241 Back     alignment and structure

Structure Templates Detected by HHsearch ?

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 1017
d1wf6a_132 c.15.1.5 (A:) DNA topoisomerase II binding protein 3e-14
d1wf6a_132 c.15.1.5 (A:) DNA topoisomerase II binding protein 1e-11
d1wf6a_132 c.15.1.5 (A:) DNA topoisomerase II binding protein 9e-10
d1wf6a_132 c.15.1.5 (A:) DNA topoisomerase II binding protein 1e-08
d1wf6a_132 c.15.1.5 (A:) DNA topoisomerase II binding protein 1e-04
d1t15a1109 c.15.1.3 (A:1649-1757) Breast cancer associated pr 1e-13
d1t15a1109 c.15.1.3 (A:1649-1757) Breast cancer associated pr 3e-12
d1t15a1109 c.15.1.3 (A:1649-1757) Breast cancer associated pr 1e-09
d1t15a1109 c.15.1.3 (A:1649-1757) Breast cancer associated pr 1e-04
d1cdza_96 c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Hom 2e-12
d1cdza_96 c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Hom 4e-11
d1cdza_96 c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Hom 2e-09
d1cdza_96 c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Hom 1e-08
d1t15a2102 c.15.1.3 (A:1758-1859) Breast cancer associated pr 1e-11
d1t15a2102 c.15.1.3 (A:1758-1859) Breast cancer associated pr 3e-07
d1t15a2102 c.15.1.3 (A:1758-1859) Breast cancer associated pr 2e-05
d1l7ba_92 c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 2e-07
d1l7ba_92 c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 4e-04
d1kzyc1153 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) 3e-05
d1kzyc1153 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) 6e-04
d1in1a_88 c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sa 7e-05
d1in1a_88 c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sa 4e-04
d1in1a_88 c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sa 0.001
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 132 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: BRCT domain
superfamily: BRCT domain
family: DNA topoisomerase II binding protein 1, TopBP1
domain: DNA topoisomerase II binding protein 1, TopBP1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (166), Expect = 3e-14
 Identities = 18/102 (17%), Positives = 36/102 (35%), Gaps = 13/102 (12%)

Query: 187 FSGLMICVTRIPADERKEMEKLIVQNGGKYSPELTKKCTHLICDISFTIYFLNFPYTPEG 246
             G  I +      +  ++ +LI   GG    +L +  TH+I                + 
Sbjct: 41  LDGCRIYLCGFSGRKLDKLRRLINSGGGVRFNQLNEDVTHVIVG------------DYDD 88

Query: 247 DKFKVAKRWG-HIHIINRKWFDQSMARRACLNEESYTVQDSS 287
           +  +   +     H++  KW  +  ++   L+EE Y     S
Sbjct: 89  ELKQFWNKSAHRPHVVGAKWLLECFSKGYMLSEEPYIHSGPS 130
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 132 Back     information, alignment and structure
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 132 Back     information, alignment and structure
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 132 Back     information, alignment and structure
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 132 Back     information, alignment and structure
>d1t15a1 c.15.1.3 (A:1649-1757) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Length = 109 Back     information, alignment and structure
>d1t15a1 c.15.1.3 (A:1649-1757) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Length = 109 Back     information, alignment and structure
>d1t15a1 c.15.1.3 (A:1649-1757) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Length = 109 Back     information, alignment and structure
>d1t15a1 c.15.1.3 (A:1649-1757) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Length = 109 Back     information, alignment and structure
>d1cdza_ c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 96 Back     information, alignment and structure
>d1cdza_ c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 96 Back     information, alignment and structure
>d1cdza_ c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 96 Back     information, alignment and structure
>d1cdza_ c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 96 Back     information, alignment and structure
>d1t15a2 c.15.1.3 (A:1758-1859) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Length = 102 Back     information, alignment and structure
>d1t15a2 c.15.1.3 (A:1758-1859) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Length = 102 Back     information, alignment and structure
>d1t15a2 c.15.1.3 (A:1758-1859) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Length = 102 Back     information, alignment and structure
>d1l7ba_ c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 {Thermus thermophilus [TaxId: 274]} Length = 92 Back     information, alignment and structure
>d1l7ba_ c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 {Thermus thermophilus [TaxId: 274]} Length = 92 Back     information, alignment and structure
>d1kzyc1 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 153 Back     information, alignment and structure
>d1kzyc1 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 153 Back     information, alignment and structure
>d1in1a_ c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 88 Back     information, alignment and structure
>d1in1a_ c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 88 Back     information, alignment and structure
>d1in1a_ c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 88 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

Original result of HHsearch against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query1017
d1wf6a_132 DNA topoisomerase II binding protein 1, TopBP1 {Hu 99.8
d1wf6a_132 DNA topoisomerase II binding protein 1, TopBP1 {Hu 99.78
d1cdza_96 DNA-repair protein XRCC1 {Human (Homo sapiens) [Ta 99.71
d1t15a1109 Breast cancer associated protein, BRCA1 {Human (Ho 99.7
d1t15a1109 Breast cancer associated protein, BRCA1 {Human (Ho 99.69
d1cdza_96 DNA-repair protein XRCC1 {Human (Homo sapiens) [Ta 99.69
d1t15a2102 Breast cancer associated protein, BRCA1 {Human (Ho 99.65
d1t15a2102 Breast cancer associated protein, BRCA1 {Human (Ho 99.6
d1l7ba_92 NAD+-dependent DNA ligase, domain 4 {Thermus therm 99.37
d1kzyc1153 53BP1 {Human (Homo sapiens) [TaxId: 9606]} 99.28
d1l7ba_92 NAD+-dependent DNA ligase, domain 4 {Thermus therm 99.27
d1in1a_88 DNA ligase III alpha {Human (Homo sapiens) [TaxId: 99.26
d1kzyc1153 53BP1 {Human (Homo sapiens) [TaxId: 9606]} 99.25
d1in1a_88 DNA ligase III alpha {Human (Homo sapiens) [TaxId: 99.21
d1l0ba297 Breast cancer associated protein, BRCA1 {Rat (Ratt 98.74
d1l0ba297 Breast cancer associated protein, BRCA1 {Rat (Ratt 98.26
d1kzyc2106 53BP1 {Human (Homo sapiens) [TaxId: 9606]} 97.83
d1kzyc2106 53BP1 {Human (Homo sapiens) [TaxId: 9606]} 97.76
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: BRCT domain
superfamily: BRCT domain
family: DNA topoisomerase II binding protein 1, TopBP1
domain: DNA topoisomerase II binding protein 1, TopBP1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2.2e-19  Score=125.55  Aligned_cols=89  Identities=29%  Similarity=0.483  Sum_probs=77.1

Q ss_pred             CCCCCCCEEEEECCCHHHHHHHHHHHHHCCCEEEEECCCCCEEEEECCCCHHHHHHHHHHHHCCCCEEECCCHHHHHHHH
Q ss_conf             67679859999267948999999999928988873049980299986787354999998550598279743278999862
Q 001761          388 DLYLSDCRIVLVGFEASEMRKLVNMVRRGGGSRYVSYNNGLTHIVVGTLSEADKREVRSLASLGIIQVVKSTWLEDCDRE  467 (1017)
Q Consensus       388 ~~~L~gc~iyl~GF~~~e~~~l~~lI~~~GGtv~~~~s~~vTHIIv~~~~~~~~~~vr~~~~~~~i~vV~~~WL~~Ci~~  467 (1017)
                      ..+|+||+|||+||+..++..|.++|..+||++.+.+++.+||||+........+..++  ....++||++.||++|+++
T Consensus        38 ~~~f~G~~i~isGf~~~~~~~l~~~i~~~GG~~~~~~~~~vTHvIv~~~~~~~~~~~~~--~~~~i~iV~~~Wl~~c~~~  115 (132)
T d1wf6a_          38 EDLLDGCRIYLCGFSGRKLDKLRRLINSGGGVRFNQLNEDVTHVIVGDYDDELKQFWNK--SAHRPHVVGAKWLLECFSK  115 (132)
T ss_dssp             TTTTTTCEEEEESCCSHHHHHHHHHHHHTTCEEESSCCSSCCEEEESSCCSHHHHHHHH--SCCCCCEEEHHHHHHHHHH
T ss_pred             HHHHCCEEEEEEECCCHHHHHHHHHHHHCCCEEECCCCCCCEEEEECCCCCCHHHHHHH--HCCCCCCCCHHHHHHHHHC
T ss_conf             55508818999607978899999999985978952037873489854788647999998--5599770799999999986


Q ss_pred             CCCCCCCCCHH
Q ss_conf             34456210000
Q 001761          468 RREISILQRHV  478 (1017)
Q Consensus       468 ~~~l~e~~~~i  478 (1017)
                      ++++|+++|.+
T Consensus       116 ~~~l~~~~Y~~  126 (132)
T d1wf6a_         116 GYMLSEEPYIH  126 (132)
T ss_dssp             SSCCCSGGGBC
T ss_pred             CCCCCHHHCCC
T ss_conf             98698786737
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1cdza_ c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1t15a1 c.15.1.3 (A:1649-1757) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1t15a1 c.15.1.3 (A:1649-1757) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1cdza_ c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1t15a2 c.15.1.3 (A:1758-1859) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1t15a2 c.15.1.3 (A:1758-1859) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1l7ba_ c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 {Thermus thermophilus [TaxId: 274]} Back     information, alignment and structure
>d1kzyc1 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1l7ba_ c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 {Thermus thermophilus [TaxId: 274]} Back     information, alignment and structure
>d1in1a_ c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1kzyc1 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1in1a_ c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1l0ba2 c.15.1.3 (A:1705-1801) Breast cancer associated protein, BRCA1 {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1l0ba2 c.15.1.3 (A:1705-1801) Breast cancer associated protein, BRCA1 {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1kzyc2 c.15.1.4 (C:1867-1972) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1kzyc2 c.15.1.4 (C:1867-1972) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure